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ABSTRACT 
Background: Bacterial adhesins, including Mycobacterium tuberculosis curli pili (MTP), are the first 
point of contact with host cells. MTP bind laminin of the extra cellular matrix and are viewed as 
bacterial virulence factors due to their key role in pathogenesis. Since the seminal paper describing 
the presence of pili in M tuberculosis, research in this field, has been steadily gaining momentum to 
further characterize this pathogen's curli pili to interrogate its potential as a biomarker for rapid 
diagnostics and therapeutic interventions. In this study, we performed global transcriptomics in a 
pulmonary epithelial cell infection model to investigate the role of MTP as a potential biomarker for 
TB diagnostics and vaccine and drug development. The epithelial cell model was chosen due to the 
increasing body of evidence demonstrating that M. tuberculosis is able to invade and survive inside 
these cells. 
Materials and Methods: RNA was extracted from A549 human alveolar epithelial cells infected 
with M tuberculosis wild type (WT) and mtp-knockout mutant strains 4 hours post-infection and 
sequenced using the Illumina HiSeq RNA Sequencing Platform. Sequencing reads were aligned to the 
human reference genome (Homo sapiens VCSC hg38) using TopHat and differential gene expression 
profiles were generated with Cuffdiff. An PPKM pairwise scatter plot comparison was performed in 
order to investigate global gene expression profiles of uninfected A549 epithelial cells relative to 
A549 cells infected with the mutant and wild type strain. Differentially expressed genes were filtered 
using a cut-off point of :::: 2 and a Venn diagram was created using the VENNY software. Gene 
Ontology analysis was performed using the Comparative Toxicogenomics Database. Heat maps of 
gene expression profiles in A549 epithelial cells infected with M. tuberculosis V9124 wild type and 
mtp-knockout strains were created using a MultiExperiment Viewer (MeV). Changes in canonical 
pathways, network and transcription factor enrichment were investigated with Ingenuity Pathway 
Analysis (IP A). The significance of differences between the two strains was analysed by one-way 
analysis of variance (ANOVA) SPSS 24.0 statistical software,p < 0.05 was considered significant. 
Results: In this study, the number of invaded bacteria observed in A549 epithelial cells infected with 
the wild type strain (2.47xl03 CPU/ml) did not differ significantly (p=0.121) when compared to the 
mtp-knockout mutant strain (l.67x103 CPU/ml). Our results further showed that, as a result of mtp 
deletion, the number of significantly differentially expressed genes and canonical pathways induced in 
A549 epithelial cells was reduced, suggesting that MTP regulates gene expression in epithelial cells in 
vitro. The WT and !::,.mtp- strains uniquely induced 307 (89 up-regulated and 218 down-regulated) and 
115 (42 up-regulated and 73 down-regulated) genes respectively while 610 (345 up-regulated and 265 
down-regulated) genes were induced by both strains. The loss of MTP resulted in a lower number, 
115 (27%) of genes induced only by the mutant strain compared to 307 (73%) by the wild type strain. 
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The wild type strain enriched a higher number of canonical pathways in epithelial cells i.e. 44 (59%) 
compared to 30 (41 %) by the mutant strain. A total of 27 pathways was unaffected by MTP as these 
were enriched by both strains. The majority of these pathways, 23 (85%), were highly enriched by the 
mutant strain compared to the wild type strain. Cell surface receptors such as CDl 4, CD24, CD38, 
CD96 and CD99 were found to be more up-regulated by the wild type strain when compared to the 
mutant strain. 
Whilst the majority of genes associated with cytokine receptors and tumor necrosis factor (TNF) 
receptors were down-regulated by both strains, the wild type strain highly up-regulated genes coding 
for chemokine receptors compared to the mutant strain. Our findings show an up-regulation of 
chemokines compared to cytokines by both strains. CCL2, CCL26, CCL28, CCL5, CXCLl, CXCL3, 
CXCL5, CXCL6 and CXCL9 chemokines and IL-11, IL-15, and IL-32 cytokines were highly up-
regulated by the wild type strain compared to the mutant strain. Genes associated with antigen 
presentation were down-regulated by both strains in epithelial cells except for HLA-DMA and HLA-
DMB. Our network analysis showed that the wild type strain enriched a similar number of networks 
when compared to the mutant strain. However, the wild type strain enriched top ranking networks 
compared to those that were enriched by the mutant strain. 
Discussion and Conclusion: In this study, the number of invaded bacteria in A549 cells infected with 
the mtp-mutant strain did not differ significantly when compared to wild type-infected A549 cells, 4 
hours post-infection. Our gene ontology and canonical pathway analyses strongly suggest that M. 
tuberculosis invades epithelial cells with the aid of one of its major adhesins, MTP, which induces 
differential host gene expression leading to the cellular and host immune response against the 
pathogen. 
The wild type strain induced the highest total number (917) of genes when compared to the mutant 
(725) while 610 genes were expressed by both strains. This reduction by 12%, in the number of genes 
expressed by the mutant strain shows that MTP plays an important role in gene regulation of alveolar 
epithelial cells. The enrichment of a high number of pathways by the wild type strain suggests that 
MTP plays an important role in gene regulation of alveolar epithelial cells. Our findings also show 
that the deletion of MTP resulted in down-regulation of some of the genes that were up-regulated in 
the wild type infection. These findings suggest that the presence of the MTP adhesin in the wild type 
strain plays an important role in the launch of a strong immune response against this strain, while the 
knocking out of the mtp gene negatively affects the ability of epithelial cells to respond to M. 
tuberculosis infection. MTP highly induced the production of chemokines in A549 epithelial cells 
compared to cytokines. This is supported by previous findings in our group that MTP did not largely 
influence cytokine production in M tuberculosis-infected epithelial cells (Ramsugit et al., 2015). /L-
XX 
1, IL-4, IL-6, IFN-Y, and G-CSFwere produced at low concentrations by epithelial cells at 24, 48 and 
72 hours post infection (Ramsugit et al., 2015). 
Our findings add to the growing evidence that M tuberculosis uses MTP as one of its major invasins 
and virulence factors during the infection of host cells. Our data confirms that epithelial cells play an 
important role in host immune response to infections. In the absence of MTP, the number of 
significantly differentially expressed genes and canonical pathways induced in A549 alveolar 
epithelial cells was reduced. Our findings further showed that alveolar epithelial cells infected with 
the wild type strain launched a stronger host immune response when compared to those infected with 
the mtp-knockout mutant strain. Taken together, these findings suggest that MTP plays an important 
role in gene regulation of A549 alveolar epithelial cells and could be a potential TB vaccine candidate 
and antimicrobial drug target. Thus, the development of rapid antimicrobial drugs and vaccines that 
target MTP would play a huge role in the treatment and prevention of TB infections as these 
structures are mainly involved in adherence to and invasion of host cells, and have been shown to 
have an ability to induce a strong immune response in epithelial cells in vitro. 
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INTRODUCTION 
Tuberculosis (TB) is an infectious bacterial disease caused by Mycobacterium tuberculosis which 
usually affects the lungs as well as the respiratory system (Mishra et al., 2014). Despite a major 
reduction in TB cases and deaths in the past decade, the disease continues to be a major public health 
problem (WHO, 2015). In 2014, about 9.6 million people developed TB and 1.5 million people died 
from the disease, making TB a leading cause of death in humans (WHO, 2015). One of the challenges 
facing TB treatment includes human immunodeficiency virus (HIV) co-infection, emergence of drug-
resistant tuberculosis (WHO, 2014) as well as the lack ofbiomarkers for early diagnosis and treatment 
(Murray, 2007). The design and development of rapid TB diagnostic tools and novel drugs is 
hampered by the shortage of suitable biomarkers that can serve as drug targets (Murray, 2007). 
Adhesins, due to their surface localisation, may serve as potential novel targets for rapid TB diagnosis 
as well as antimicrobial drugs and vaccine development (Kumar et al., 2013). 
Attachment of pathogenic bacteria to any mucosal surfaces is an essential step in the pathogenesis of 
many infections. In order to achieve this, bacteria make use of an array of adhesins displayed at their 
cell surfaces. These highly specific proteins are usually expressed at different stages during infection 
(Kumar et al., 2013). Interactions between infecting bacteria and host cells are aided by specialized 
microbial adhesins that modulate binding to the surface of host cells (Klemm and Schembri, 2000). 
Adhesins allow pathogenic bacteria to attach to host cells and resist physical removal from the surface 
and that leads to invasion and induction of the host immune response (Niemann et al., 2004). 
Microbial adhesins usually appear as polymeric organelle structures as well as non-organelle 
structures attached to the surface of bacterial cells as monomers or oligomers (Klemm and Schembri, 
2000). 
M. tuberculosis expresses a number of different essential adhesins including heparin-binding 
hemagglutinin adhesin (HBHA), Apa, malate synthase (MS), 19 kDa antigen, laminin binding protein 
(LBP) (Kumar et al., 2013) and curli pili (MTP) (Alteri et al., 2007). HBHA is involved in binding of 
bacteria to lungs and in extrapulmonary dissemination of the bacteria (Kumar et al., 2013). Curli pili 
(MTP) bind laminin and are produced during the infection of host cells (Alteri et al., 2007). MTP, 
encoded by the mtp gene (Rv3312A), is viewed as a bacterial virulence factor due to its key role in 
pathogenesis and is therefore an important target for vaccine and drug development (Finlay and 
Falkow, 1997). MTP is associated with biological activities such as colonization of mucosal surfaces, 
agglutination of human and animal red blood cells, biofilm formation and bacterial adherence (Finlay 
and Falkow, 1997). M tuberculosis interacts with and invades different animal and human epithelial 
cells. However, very little is known about the interactions that take place between the microbe and 
host cells before bacterial survival and replication (Lin et al., 1998). Previous studies have indicated 
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that alveolar epithelial cells play a significant role in immune response by recruiting immune cells 
such as lymphocytes, neutrophils and monocytes to the site of infection through cytokine and 
chemokine production (Lin et al., 1998). 
Different technologies used to study host-pathogen interactions have been developed and some of 
these include hybridization-based techniques such as microarrays (Mantione et al., 2014). This is a 
high throughput technique that has been widely used in whole genome studies in the past due to its 
inexpensive nature (Wang et al., 2009). However, microarrays have high levels of background noise 
owing to cross-hydridization and have a limited range of detection (Mantione et al., 2014). RNA 
sequencing, a recently developed technique for whole transcriptome profiling, can achieve a higher 
resolution and has a much lower limit of detection compared to microarrays (Wang et al., 2009). In 
this study, we used whole transcriptome analysis in order to investigate the role of MTP in gene 
regulation of A549 pulmonary epithelial cells infected with mtp-gene knockout mutant and wild type 
strains of M. tuberculosis V9124, a clinical isolate of the F15/LAM4/KZN (KZN) family. 
Dissertation Outline 
The first chapter presents a review of the relevant literature. Chapter 2 describes all the methods that 
were used in order to carry out objectives of the study. Chapter 3 presents the results that we obtained 
in the study while chapter 4 provides a discussion which integrates the findings of chapter 3 and 
highlights conclusions and future recommendations. 
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CHAPTER 1: LITERATURE REVIEW 
1.1. Epidemiology of TB 
Mycobacterium tuberculosis is a causative agent of tuberculosis (TB), a deadly disease that caused 
about 1.5 million deaths while 9.6 million new cases were reported in 2014 and is now ranked as the 
leading cause of death in human population (WHO, 2015). M tuberculosis is a Gram-positive bacillus 
with a cell wall rich in mycolic acid, an unusual waxy coating that makes the cells impervious to gram 
staining and its physiology requires high levels of oxygen and Mg (2+) in a mildly acidic environment 
(Kassim, 2004). Inhalation of airborne M tuberculosis bacilli, followed by adherence and invasion of 
cells located at the surface of the lungs leads to a successful establishment of a TB infection (Hickey 
et al., 2010). M. tuberculosis primarily infects the lungs where it causes pulmonary TB infections. 
However, it can also disseminate to other body parts such as lymphatic, central nervous and 
genitourinary systems, where it causes extra pulmonary TB infections which are more common in 
children and immune compromised individuals (WHO, 2015). About one third of the world's 
population harbours M. tuberculosis in a latent form that shows no clinical symptoms and is difficult 
to diagnose (WHO, 2015). 
Despite a slight decline in global TB rates over the years, South Africa (SA) remains one of the worst 
hit countries by TB. Among high TB-burden countries, SA has the third and fifth highest number of 
reported TB cases and undiagnosed active TB cases respectively (Churchyard et al., 2014). The 
growing burden of MDR-TB coupled with the emergence ofXDR-TB in 2006 added a further load to 
overstretched health facilities (Churchyard et al., 2014). The increase and decline in cure rates and 
treatment default respectively, has increased TB treatment success rate in SA, for both new smear 
positive and smear negative TB patients (WHO, 2015). The high mortality rate even after treatment 
completion could be attributed to the HIV disease (Abdool Karim et al., 2009). Therefore, scaling up 
antiretroviral therapy (ART) in TB patients infected with HIV is needed in order to reduce HIV-
related deaths (Churchyard et al., 2014). SA has made notable progress in enhancing TB control, 
however, the TB burden remains very high. 
A study conducted by Hassim et al. (2010) revealed that about 20% of people with TB/HIV co-
infection in SA were infected with MDR-TB strains, introducing a major stumbling block in fighting 
the worsening TB/HIV pandemic. The KwaZulu-Natal (KZN) province in SA is the epicenter of 
TB/HIV co-epidemic with an HIV prevalence of about 40% and TB notification rate of 1094/100 000 
population (Houlihan et al., 2010; Health Systems Trust, 2011). KZN experienced a well-documented 
MDR and XDR-TB outbreak and remains one of the provinces with the highest burden of these types 
of TB infection (Gandhi et al., 2006; Bateman, 2010). Absent or delayed TB diagnosis leads to the 
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delay of TB treatment, therefore increasing transmission and mortality and morbidity rates 
(Kasprowicz et al., 2011). Autopsy studies in SA have revealed that up to 50% of patients with HIV 
infection or AIDS have TB infection at their time of death (Ansari et al., 2002; Cohen et al., 2010). 
Furthermore, 17% of HIV-related TB cases at death were due to MDR strains (Cohen et al., 2010). 
1.2. Drug resistance 
1.2.1. Multidrug-resistant TB (MDR-TB) 
M. tuberculosis is a very slow growing intracellular organism, therefore, TB treatment requires the 
use of multiple antimicrobial drugs such as isoniazid (INH), rifampin (RIF), ethambutol (EMB) and 
pyrazinamide (PZA) which are considered first-line anti-tuberculosis drugs and aminoglycosides, 
fluoroquinolones, polypeptides, thioamides, cycloserine and p-aminosalicylic acid which are second-
line drugs (WHO, 2015). TB infection caused by M tuberculosis resistant to at least INH and RIF is 
referred to as multidrug-resistant TB (MDR-TB). Globally, 5% of TB cases were estimated to have 
had MDR-TB in 2014. Drug resistance surveillance data revealed that about 480 000 people were 
infected with MDR-TB in 2014 and 190 000 people died as a result (WHO, 2015). An estimation of 
about 1.8% of new TB cases and 6.7% of previously treated TB cases in SA are multi drug resistant 
(WHO, 2014). However, the majority of new MDR-TB cases are as a result of transmission of already 
resistant strains (Dheda et al., 2010). Unpublished data from the Western Cape department of Health 
revealed that half of new MDR-TB cases diagnosed every year have never received treatment 
(Hughes and Osman, 2014). MDR-TB surveillance in KZN, especially Tugella Ferry, revealed that an 
extraordinary high incidence of TB in the area. Among MDR and XDR-TB patients, the rate of HIV 
co-infection was reported to be more than 90% (Giffin and Robinson, 2009). 
1.2.2. Extensively drug-resistant TB (XDR-TB) 
TB infection resistant to INH and RIF as well as to any member of the fluoroquinolone family and 
one of the aminoglycosides or polypeptides is known as extensively drug-resistant TB (XDR-TB) 
(WHO, 2015). In 2014, XDR-TB was reported by 105 countries globally, with an estimated average 
of9.7% people with MDR-TB having XDR-TB (WHO, 2015). This type of TB infection is associated 
with the development of resistance towards drugs in virulent M. tuberculosis strains as well as with 
poor treatment outcomes, especially among individuals infected with HIV (Tsara et al., 2009; Shah et 
al., 2011). XDR-TB strains arise when MDR-TB is treated poorly, which allows amplification of 
resistance towards second-line drugs. Inadequate treatment for XDR-TB may result in additional 
resistance which could limit options for effective TB treatment (Shah et al., 2011). Early diagnosis 
and treatment of infectious patients with active pulmonary TB is considered crucial in decreasing the 
transmission and possibly the elimination of M. tuberculosis (Tsara et al., 2009). Moreover, early 
identification and treatment of individuals with latent TB infections is important for disease control 
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due to their high risk to develop active TB infection. In SA, 10% of MOR cases are XOR (WHO, 
2014) and initial treatment of these cases with MOR drugs is suspected to contribute to amplified drug 
resistance as a result of selective pressure of treatment with one or two effective drugs (Muller et al., 
2012). In 2007, XOR had been reported by 60 health care facilities in KZN. A total of 47 000 case of 
TB had been reported with 6% of them being XOR. According to the WHO 2013 TB report, treatment 
success rate was 48% and 22-28% for MOR and XOR respectively, with a death rate of 44-49% in 
individuals with XOR-TB (Muller et al., 2012). 
1.2.3. Totally drug-resistant TB (TDR-TB) 
Totally drug-resistant TB (TOR-TB) is acquired as a result of resistance to all first- and second line 
drugs used to treat TB (Parida et al., 2014). TOR-TB was first discovered in two patients in Italy in 
2003 and subsequently reported in 2007 (Migliori et al., 2007). Iran reported second TOR-TB cases 
where 10.3% M. tuberculosis isolates from 146 patients with MOR-TB were found to have TOR-TB 
infection (Velayati et al., 2009). Other TOR-TB cases have been reported in India while 92% of 236 
MDR-TB strains collected in SA belonged to an atypical Beijing strain genotype that is resistant to 10 
first- and second line anti-TB drugs. Some of these strains were reported to be resistant to para-
aminosallicylate sodium (PAS), suggesting the emergence of TDR-TB in SA (Klapper et al., 2013). 
TDR-TB has only been reported in four countries (Italy, Iran, India and SA) so far, however, factors 
such as limited laboratory access to in resource-limited countries with high TB prevalence could lead 
to the under-representation of the real extent of drug resistance in M tuberculosis isolates (Parida et 
al., 2014). 
1.3. Vaccines 
New TB treatment strategies are needed, but the most effective tool would be a vaccine that prevents 
infections (Barker et al., 2011). Current TB research strategies have mainly focused on the 
development of an improved bacilli Calmette-Guerin (BCG) vaccine to be given at birth and a booster 
vaccine to be administered after BCG (Checkley and McShane, 2011). In case-control studies, the 
BCG vaccine given to newborns has often been associated with reduced severity of childhood TB, 
including brain-affecting meningeal TB and disseminated miliary TB (Barker et al., 2011). However, 
administering the vaccine to newborns does not seem to offer protection against adult pulmonary TB 
which is accountable for the global TB morbidity and mortality burden (WHO, 2014). The 
reactivation of latent TB infection to active TB and re-infection with M. tuberculosis after successful 
TB treatment indicates that immune response to TB infection is complex, therefore, multiple vaccines 
may need to be developed (Barker et al., 2011). A major stumbling block in the development of an 
effective vaccine against TB infection is the lack of understanding of the host immune response to M. 
tuberculosis that is associated with protection (Barker et al., 2011). However, studies on CD4, CDS 
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and Thl 7 T cells have revealed that these cells can specifically target M. tuberculosis and produce 
multiple signalling molecules that offer protection to host cells (Barker et al., 2011). 
Apart from not being effective against adult active TB, some studies have shown that the BCG 
vaccine enhances the risk of M tuberculosis infection (D' Arey and Sutherland, 1977; Baily, 1979; 
Sadoff, 2009). A South African TB Vaccine Initiative in the Western Cape province of SA conducted 
a trial in > 10 000 infants over 18 months and found a 4.5% incidence of the disease despite routine 
BCG vaccination (Hawkridge et al., 2008). The spread of HIV infection, which is concentrated in 
areas with high TB burden, offers an additional risk when the BCG vaccine is administered to HIV -
infected infants. Despite being a highly attenuated live vaccine, the BCG vaccine causes extra-
pulmonary TB in HIV-infected children at rates as high as 1 % (Beresford and Sadoff, 2010) and it is 
for this reason that the WHO has recommended that the vaccine should not be administered to HIV -
infected infants. Most infants are not tested for HIV infection and this provides a major problem to 
policy makers in allowing vaccination and risk diseases in HIV-infected children or not to allow 
vaccination and risk the development of different forms of the TB disease which children infected 
with HIV are susceptible to (Hesseling et al., 2009). The effectiveness of the BCG vaccine coupled 
with the risk of adverse effects demands the development of better vaccines to offer protection to 
everyone. 
1.4.Anti-TB drugs 
Current TB treatment is based on different combinations of drugs with high cure rates for drug-
susceptible strains of M. tuberculosis when lengthy and complex treatment protocols are adhered to 
(Laurenzi et al., 2007). However, the lack of adherence to treatment protocols, incorrect prescribing 
of drugs, emergence of drug-resistant TB and drug-to-drug interaction that interferes with optimal 
treatment of HIV and TB co-infection have generated a need for improved TB treatment interventions 
(Laurenzi et al., 2007). Current drugs used to treat TB were developed decades ago when both drug 
development processes and regulatory environments significantly differed from today's processes 
(Laurenzi et al., 2007). Success rates achieved by these drugs are high but still need complex and 
more recent processing protocols. Drugs with different mechanisms of action are likely to kill various 
populations of bacteria (Ying, 2003). Isonaizid is the most active of the current TB drugs against 
actively replicating M tuberculosis while rifampicin is active against both actively replicating and 
non-replicating mycobacteria through the inhibition of RNA synthesis (Ying, 2003). 
Problems associated with current TB drugs include the longevity and the complex nature of treatment 
protocols which impact negatively on patient adherence and drive the emergence of drug-resistant TB 
(Laurenzi et al., 2007). Reasons for inadequate TB treatment include incomplete implementation of 
regimens especially the duration of treatment, drug quality and number of drugs and their dosages 
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(van den Boogard et al., 2009). Another challenge for the successful treatment of TB is the high 
prevalence if HIV and TB co-infection as these two infections are synergistic and the risk of 
progression from latent TB to active TB is estimated to be 50-fold higher in HIV-infected individuals 
compared to HIV negative patients (WHO, 2003). Current TB drugs have been reported to have side 
effects such as liver disfunctioning, hepatotoxicity, ototoxicity, neuropsychiatric manifestations and 
hyperuricemia (Gulbay et al., 2006). There's an urgent need to improve current TB treatment 
strategies by either introducing new drugs on the pipeline or enhancing the application of existing 
ones. Potential new drugs should have reduced treatment duration, be active against MDR and XDR-
TB, be applicable in TB patients infected with HIV, have a good and acceptable profile of tolerability, 
be readily available in all healthcare facilities, have a reduced cost for better access in developing 
countries with high TB burden and they must also be active against latent TB infections (van den 
Boogard et al., 2009). Novel biomarkers are urgently needed to satisfy these criteria for the 
development of effective drugs. 
1.5. Immunotherapeutics for TB Treatment 
Granulomas, a hallmark of the host response to M tuberculosis infection, are employed by host cells 
in order to physically contain infections that cannot be removed by host cell defences (Wallis, 2005). 
The sequential recruitment of host immune cells towards the site of infection creates a barrier that 
prevents dissemination of M tuberculosis and provides a hostile environment with reduced pH, 
micronutrients and oxygen tension (Wallis, 2005). M tuberculosis undergoes alterations in 
biosynthesis, metabolism and replication when faced with this hostile environment and this adaptation 
forms the basis of latency in TB infection (Wallis, 2005). The reactivation of M tuberculosis latency 
to active TB which has poor treatment outcomes has given rise to the development of adjunct 
immunotherapy to treat TB (Uhlin et al., 2012). Dampening of pro inflammatory response to TB 
could be of value in the treatment of individuals with non-productive TB infection (Uhlin et al., 
2012). The use of interleukin 2 (IL-2), interferon Y (IFN-Y) and tumor necrosis factor (TNF) in 
immunotherapy may increase success rates in the treatment of MDR-TB and could shorten the time it 
takes to treat drug-susceptible TB by improving the immune system of infected individuals through 
the elimination of M. tuberculosis to prevent TB recurrence (Wallis, 2005; Uhlin et al, 2012). 
JFN-Y'plays an essential role in host immune response against mycobacteria (Jouanguy et al., 1996). 
In mice, it increases the mycobactericidal ability of macrophages through the production of reactive 
nitrogen intermediates (Flesch and Kaufmann, 1987; Chan et al., 1992). Condos et al. (1997) 
conducted the first trial of therapeutic IFN-Y in patients with TB where they found no defects in IFN-
Y' production or responsiveness. In this study, 500µg of IFN-Y' was administered 3 times a week to 
patients with MDR-TB and their sputum smear results were negative while the number of colony 
forming units (CPUs) decreased. IL-2 is essential for host immune cell functioning and also promote 
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T cell replication (Wallis, 2005). In a study conducted in 1997, the administration of 2 low-dose IL-2 
regimens per day to patients with MDR-TB was found to have decreased CFU counts (Johnson et al., 
1997). The TNF cytokine is expressed by T cells and macrophages as a cell surface-associated 
cytokine or soluble homotrimer (Wallis et al., 1990; Black et al., 1997). TNF is also involved in the 
stimulation of cytokine and chemokine release, as well as endothelial adhesion molecules (Wallis et 
al., 1990). TNF is expressed at the site of infection in patients with newly diagnosed TB and its levels 
increase after the initiation of anti-tuberculosis therapy (Bekker et al., 1998) and decrease when the 
mycobacterial burden is reduced by treatment (Ribeiro-Rodrigues et al., 2002). Animals that lack 
TNF have been found to be more susceptible to granulomatous infections (Flynn et al., 1995). This 
makes TNF a suitable candidate for immunotherapeutic treatment of TB infections. Due to challenges 
associated with current TB diagnostic tools anti-TB drugs, an area of TB treatment using 
immunotherapy needs to be investigated further. M tuberculosis adhesins, that have been identified to 
play a significant role in modulating host response, could potentially contribute to this type of adjunct 
therapy, and therefore, should be included in such investigations. 
1.6. TB Diagnostic Techniques and Challenges 
TB can be diagnosed through a number of diagnostic tests e.g. tuberculin skin tests, chest x-rays, 
sputum smear microscopy and sputum culture. The most common method for TB diagnosis 
worldwide is sputum smear microscopy (WHO, 2013). It is a cost-effective test with low sensitivity 
and can miss up to 40% of all TB cases especially in regions with high HIV I AIDS incidence 
(Maertzdorf et al., 2007). The sputum culture test is costly but more sensitive. However, it takes 
several weeks to produce results and this could lead to the transmission of TB during the waiting 
period. 
In order to achieve higher sensitivity and specificity compared to the traditional microscopic sputum 
examination and culture based methods, new rapid and accurate diagnostic methods need to be put 
into place (Tsara et al., 2009). Current TB diagnostic methods are characterized by low specificity, 
reduced sensitivity as well as false results that can even occur in severely ill patients. Substantial 
research has led to the development of diagnostic tests such as nucleic acid amplification (NAA) tests 
that can be applied directly to sputum samples (Tsara et al., 2009). 
The Genotype MTBDRplus test, a line-probe assay (LP A), is used for rapid detection of 
Mycobacterium tuberculosis and mutations that result to resistance to rifampin and isoniazid in smear-
positive sputum specimens (Chainani, 2013). Genotype MTBDRplus is used in the rapid diagnosis of 
MDR-TB in known, smear-positive TB cases in which drug-resistance is suspected and in culture 
isolates. However, it has a sensitivity of 84.3% and 98.1 % for INH and RIF respectively (Chainani, 
2013). This means that it can miss TB cases in patients with low mycobacterial load therefore, further 
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testing is always needed. The Line Probe Assay uses multiplex PCR amplification and reverse 
hybridization to identify M. tuberculosis complex and mutations associated with rifampicin and 
isoniazid resistance and has been recommended by WHO for rapid screening of MDR-TB in low and 
middle income settings (Albert et al., 2010). It is highly specific, sensitive and can be performed 
directly from culture isolates or smear-positive sputum providing results in 1-2 days. However, false 
results have been reported (Albert et al., 2010). 
In December 2010, the World Health Organization introduced a novel rapid test for tuberculosis, the 
GeneXpert (Xpert MTB/RIF). This cartridge based machine is a fully automated nucleic acid 
amplification test (NAAT) capable of diagnosing TB and resistance to rifampicin (an indicator for 
MDR-TB) within two hours (WHO SA, 2011). However, it is not regarded as a point of care test due 
to its expensive nature and the machine can only be operated by trained personnel (WHO, 2011). 
Amplicor MTB test and the Amplifier Mycobacterial Tuberculosis Direct test are characterized by 
high specificity in positive sputum smear and short times needed for the diagnosis (Tsara et al., 2009). 
However, these NAA tests need to be confirmed by sputum culture and they have low specificity and 
sensitivity for extra-pulmonary TB (Tsara et al., 2009). In addition, molecular-based methods are 
laboratory based and require expensive equipment as well as specialized personnel (WHO, 2013). 
The need to facilitate early TB treatment and disease transmission has led to the discovery of potential 
point of care tests such as the Immunochromatographic Test (ICT) (Gounder et al., 2002), Capilia TB 
Assay (Muyoyeta et al., 2010), Urine Lipoarabinomannan (LAM) (Peter et al., 2013) and the MPB64 
Antigen Assay (Nakamura et al., 1998). ICT is a rapid, card-based immunochromatographic test that 
is used to detect antibodies directed against M tuberculosis antigens. Since target proteins are 
secreted by actively growing mycobacteria, ICT has the potential to have a higher degree of 
specificity for active TB infections and the use of multiple antigens may increase its sensitivity 
(Gounder et al., 2002). However, serologically based tests are often associated with cross reactivity 
which leads to low sensitivity (Pai and Pai, 2012). 
Muyoyeta et al. (2010) evaluated the performance and cost of the Capilia TB Assay in South Africa 
and Zambia for its use in resource-limited settings. The assay was found to have a specificity and 
sensitivity of 99.5% and 99.6% respectively. These findings indicate that the Capilia TB Assay is an 
inexpensive, rapid and simple M. tuberculosis identification test that can be applied in resource-
limited settings. However, its use has been validated on culture and not on sputum specimens 
(Muyoyeta et al., 2010). Urinary LAM has recently been studied for diagnosis of TB in HN-infected 
patients (Peter et al., 2010). The presence of LAM in patients has been associated with higher 
mycobacterial burden and mortality rate (Talbot et al., 2012). LAM is detected by a low cost and 
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simple point of care lateral assay that provides results in 25 minutes (Peter et al., 2010). However, it 
remains unclear whether this test would be useful in high HIV prevalence settings (Peter et al., 2013). 
MPB64, an antigen specific to the M. tuberculosis complex, was first described as MPT64 and has 
been well studied in laboratories (Nakamura et al., 1998). This antigen is used as a skin test reagent 
for the diagnosis of TB in patients. The use of the MPB64 Patch Assay as a point of care test to detect 
active TB is promising, however, it is only applicable in patients with active TB infections (Kumar et 
al. , 2011 ). The design and development of rapid TB diagnostics, novel drugs and an effective vaccine 
is hampered by the lack of suitable biomarkers that can serve as targets, despite the considerable 
amount of research that has been conducted in this area. 
1.7. M. tuberculosis Characteristics 
M tuberculosis is classified as a Gram-positive bacterium, due to its unique cell wall composition 
which causes poor staining with crystal violet (Ducati et al., 2006). The bacterium is rod-shaped, non-
sporulating and does not have a flagellum or capsule (Ghosh et al., 2009). Its waxy and complex cell 
wall gives the bacillus acid-fast properties, making it resistant to decolourization by acids during 
staining procedures (Welin, 2011). M tuberculosis is a very slow-replicating bacterium with a 
doubling time of about 24 hours (Welin, 2011). It has a diameter of 0.5 µm and a length of about 1-4 
µm and is a facultative anaerobic intracellular pathogen (Ducati et al. , 2006). Its uniquely composed 
cell wall consists of long chains of fatty acids called mycolic acids (Figure 1) that are linked to a 
peptidoglycan-attached arabinogalactan (Welin, 2011). The cell wall comprises several lipoglycans 
such as lipoarabinomannan (LAM), its precursor lipomannan (LM) and phosphatidyl-myo-
inositolmannosides (PIM) (W elin, 2011 ). All these components are non-covalently attached to the 
plasma membrane through glycophosphatidylinositol (GPI) anchors and extend to the exterior of the 
cell wall (Ducati et al., 2006; Briken et al., 2004). LAM is made up of a phosphatidyl-myo-inositol 
anchor, a D-mannan polymer attached to the inositol ring, D-arabinose chains and capping motifs that 



















Figure 1: M tuberculosis cell wall. Arabinogalactan is attached to the peptidoglycan through 
phosphatidyl-myo-inositolmannoside. Mycolic acids and glycolipids extend through the cell wall. 
(Welin, 2011). 
M tuberculosis uses LAM as one of its virulence factors to inhibit functions of macrophages that are 
important for killing the pathogen (Briken et al., 2004). These virulence factors inhibit phagosomal 
maturation and disrupt cell signalling and pro inflammatory response through cytokine production 
(Briken et al., 2004; Pathak et al., 2005; Vergne et al., 2005). Slow-growing and virulent 
mycobacteria consist of mannose-capped LAM (ManLAM) in their cell wall while fast-growing and 
non-virulent mycobacteria such as M. smegmantis consist of non-capped AraLAM or phosphor-myo-
inositol-capped LAM (PILAM). It is this type of capping that is essential for the virulence of 
mycobacteria (Dao et al., 2004). The cell wall of M. tuberculosis also consists of 19-kDa lipoprotein 
with no known function but has been reported to be involved in virulence through a role it plays in 
host cell death and manipulation of bactericidal pathways (Ciaramella et al., 2000). This lipoprotein, 
as well as LM and AraLAM of fast-growing mycobacteria induce an immune response in host cells 
by binding to Toll-like receptors (TLRs) on the host cell surface (Means et al. , 1999; Ciaramella et 
al., 2004). 
1.8. TB Pathogenesis 
The inhalation of mycobacterium bacilli which are released from an infected individual through 
coughing or sneezing is one of many ways that cause TB transmission (Welin, 2011). After 
inhalation, the bacterium is taken up by phagocytic alveolar macrophages and dendritic cells (Fogel, 
2015). The majority of individuals who inhale mycobacterium bacilli have the ability to launch an 
effective immune response in the lungs which leads to the inhibition of mycobacterial growth inside 
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host cells (Thillai et al., 2014). Growth inhibition leads to the bacteria becoming dormant and this 
type of infection is referred to as latent TB infection (LTBI). Immunocompetent individuals infected 
with LTBI do not show TB symptoms and are unable to transmit it (WHO, 2014). In this case, the 
growth of M. tuberculosis is controlled by antimicrobial peptides or keeping mycobacteria within the 
granuloma allowing the adaptive immunity to prevent the development of an infection to a disease 
(Goldman and Schafer, 2011). However, even after years of latency, resuscitation-promoting factor 
(RPF) proteins can be activated allowing mycobacteria to revert from a latent to an active state and 
resume cell division (Chao and Rubin, 2010). In addition, toxin-antitoxin (TA) gene pairs and plasmid 
maintenance factors encoded by M tuberculosis also play a huge role in the switch from latency to 
reactivation through the production of a cell-killing toxin which gets neutralized by an antitoxin that is 
degraded later (Chao and Rubin, 2010). 
Approximately 5-10% of individuals infected with LTBI are at risk of developing active (primary) TB 
(Cruz-Knight and Blake-Gumbs, 2014). These include immunocompromised individuals such as 
those infected with HIV, cancer and persons taking immunosupressing medication (Cruz-Knight and 
Blake-Gumbs, 2014). Granulomas have always been viewed as beneficial only for host cells, but 
studies have indicated that mycobacteria use granulomas for their own benefit. The recruitment of 
host cells to the granuloma allows an easy spread of mycobacteria to new host cells once they've 
killed their primary host cells (Davis and Ramakrishnan, 2009). In active TB, the granuloma contains 
necrotic macrophages which form cavities in the lungs (Russell, 2007). Rapturing of cavity structures 
causes the spillage of infectious bacilli into the airways, allowing the spread of mycobacteria to 
surrounding host cells (de Chastellier, 2009). Pulmonary TB which results in symptoms such as 
weight loss, dry and bloody cough and night sweats is the most common form of TB infection (Ducati 
et al., 2006). However, the spread of mycobacteria through lymph nodes can cause extra-pulmonary 
TB infection which affects the brain and the spine (Donoghue, 2009). 
1.9. TB Immunology 
The inhalation of mycobacterium bacilli results in their interaction with macrophages which are 
immune cells with the ability to phagocytose and kill bacteria (Fogel, 2015; Peters and Ernst, 2003). If 
bacilli are not killed during this interaction, they proliferate within macrophages and dendritic cells at 
a rapid rate leading to the production of pro-inflammatory cytokines such as IL-1~ and IL-la (Fogel, 
2015). M. tuberculosis expresses pathogen-associated molecular patterns (PAMPs) on its surface and 
these are recognized by pattern recognition receptors (PRRs) located at the surface of macrophages 
and dendritic cells (Hossain and Norazmi, 2013). The uptake of M tuberculosis is mediated by toll-
like receptors (TLRs) of host cells (Figure 2) leading to cytokine production due to the induction of 
intracellular signalling cascade (Sakamoto, 2012; de Martino et al., 2014). M. tuberculosis 
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proliferates within host cells during early innate immune response and induces death via the ESXl 











Figure 2: Cell biology of M. tuberculosis infection. The bacterium interacts with macrophages 
through a wide range of receptors located at the surface of the host cell. Phagocytic PRRs include the 
Fe receptor (FcR), complement receptors (CRl, CR3 and CR4), mannose receptor (MR), scavenger 
receptors (SR) and surfactant protein receptors (SPR). The CD14 receptor is involved in TLR 
signalling. TLRs are expressed at phagosomal and plasma membranes where they induce cytokine 
production via the MyD88 signalling pathway. (Sakomoto, 2012). 
Dendritic cells transport rnycobacteria to the lymph nodes (Figure 3) where T cells are activated by 
antigen-presenting cells (APCs) (Peters and Ernst, 2003) allowing rnycobacteria to be loaded onto 
major histocornpatibility complex (MHC) class II (Shaler et al., 2013). Activated T helper cells move 
to the lungs where they secrete IFN-Y cytokines and activate the adaptive immune response, 
including CD4+ and CD8+ T cells (Shaler et al., 2013). M tuberculosis accumulates mutations during 
this period and can change the expression of some of its genes and surface antigens in order to evade 
T-cell recognition (Shaler et al., 2013). 
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Figure 3: Cell trafficking during host immune response to M tuberculosis. Host immune cells 
involved in immune response are indicated by numbers: (1) monocyte, (2) dendritic cell precursor, (3) 
tissue macrophages, ( 4) immature dendritic cell, ( 5) mature dendritic cell, ( 6) T-cell progenitor, (7) 
naive T cell, (8) effector T cell. (Peters and Ernst, 2003). 
After continuous cytokine production, T cells limit the movement of macrophages and activate them 
for granuloma formation (Figure 4) which is composed of macrophages, neutrophils, monocytes, 
dendritic cells and T cells (Peters and Ernst, 2003; Shaler et al., 2013). Some studies have shown that 
granuloma formation might control the growth of M tuberculosis, however, mycobacteria can 
manipulate granulomas for their own benefit by altering the immune response through IL-10 which 
suppresses the activation of T cells and macrophages (de Martino et al., 2014). Knockout studies in 
mice have indicated a small reduction in bacterial load suggesting that M. tuberculosis might make 





Figure 4: Granuloma formation in response to M tuberculosis infection. T cells limit the movement 
of macrophages and activate them for granuloma formation which is composed of macrophages, 
neutrophils, monocytes, dendritic cells and T cells. (Peters and Ernst, 2003). 
Mechanisms of M. tuberculosis survival inside macrophages has been studied extensively, however, 
there's about 30 000 alveolar epithelial cells and 50 macrophages per alveolus (Crandall and Kim, 
1991; Crystal, 1991; Schneeberger, 1991). Recent studies have demonstrated the presence of viable 
mycobacteria and M tuberculosis DNA in non-macrophage cells from lungs, kidneys and spleen of 
latently infected subjects (Barrios-Payan et al., 2012). Studies in M tuberculosis-infected mice 
showed an extensive replication of M. tuberculosis in non-migrating compartments of epithelial cells 
which do not present antigens to CD4+ cells during the first 2-3 weeks after infection (Wolf et al., 
2008). However, Cunningham et al. (1994) reported that alveolar epithelial cells most likely play a 
role in antigen presentation via MHC class I molecules. Mvubu et al. (2016) demonstrated an 
increased expression of HLA-B, HLA-C, HLA-F and HLA-H genes in alveolar pulmonary epithelial 
cells infected with various M. tuberculosis strains for 48 hours. These studies revealed that post 
inhalation, apart from macrophages, M. tuberculosis invades and replicate in alveolar epithelial cells 
which provide a suitable environment for rapid replication and protect mycobacteria from phagocytic 
cells (Ryndak et al., 2015). Mehta et al. (1996) reported that A549 alveolar epithelial cells offer a 
suitable environment in which M. tuberculosis replicates about more than 55-fold in a 7-day period 
compared to 3-fold in macrophages. 
Epithelial cells may be the first point of contact with the pathogen due to their over-representation in 
the alveolar space compared to macrophages (Li et al., 2012). M tuberculosis uses cell surface-bound 
adhesins in order to adhere to, and invade epithelial cells (Ryndak et al., 2015), and is known to 
produce multiple adhesins in order to enhance its entry into host cells via extracellular matrix proteins 
(Ryndak et al., 2015). Recent studies have suggested that MTP may be a major adhesin and invasin of 
macrophages (Ramsugit and Pillay, 2014) and epithelial cells (Ramsugit et al., 2016) by binding to 
the laminin protein of the extracellular matrix in vitro (Alteri et al., 2007) but does not largely 
influence the overall cytokine response in epithelial cells (Ramsugit et al., 2016). M tuberculosis has 
been known to induce immune response in macrophages by eliciting cytokine and chemokine 
production which leads to the recruitment of neutrophils, dendritic and natural killer cells towards the 
site of infection (Welin, 2011; Peters and Ernst, 2003; Fogel, 2015). Previous studies conducted using 
RT-PCR have implicated human alveolar epithelial cells in the production of IL-8 and MCP-1 (Lin et 
al., 1998), CXCL-10, TNF-o. and CCL-5 (Lam et al., 2010) and IL-Ip, IL-6, TNF-o. and MCP-1 
(Savard et al., 2002) contributing to the activation of immune cells and pro inflammatory response 
(DiMango et al., 1995; Jung et al., 1995; Lin et al., 1998). 
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1.10. TB Biomarkers 
One of the main problems associated with current TB diagnostic tests is the lack of biomarkers, which 
are defined as biological characteristics that can be evaluated and measured as indicators of 
pathological processes e.g. a response to a therapeutic drug or preventive vaccine (Maertzdorf et al., 
2007). Biomarkers reliably diagnose active TB, predict risk of disease progression and could facilitate 
rapid diagnosis and treatment of patients (Maertzdmf et al., 2007). Moreover, biomarkers have a 
potential to speed up clinical trials with novel vaccine and drug candidates in the pipeline. This could 
overcome the problem of the lack of newer drugs to treat MDR-TB and XDR-TB, therefore a simple 
and low cost biomarker-based point of care test is of essentiality (Maertzdorf et al., 2007). An 
effective TB vaccine could have a significant impact on the current TB pandemic. 
Studies on M. tuberculosis biomarkers have mainly focused on predicting treatment efficacy and cure 
of active TB, activation of LTBI and induction of protective immune response by vaccination (Wallis 
et al., 2013). Inflammation-based biomarkers such as the C-reactive protein lack predictive value for 
clinical use due to their non-specific nature (Wallis et al., 2013). The most-robust biomarkers measure 
essential factors associated with pathological processes of the disease being treated in order to capture 
effects of different of types of interventions on clinical outcomes (Maertzdorf et al., 2007). The 
detection of M. tuberculosis DNA in sputum correlates with a mycobacterial burden at the time of TB 
diagnosis but cannot distinguish between live and dead mycobacteria as the treatment progresses 
(Hellyer et al., 1999). High levels of neopterin, which is a non-specific marker for macrophage 
activation, that persist during TB treatment are associated with an increased rate of relapse and LTBI 
activation in patients infected with HN-1 (Hosp et al., 1997x). PCR-based methods for the 
quantification of active mycobacteria have been successfully applied in the development of TB 
biomarkers thus far. The GeneXpert MTB/RIF assay, a highly sensitive, automated and rapid 
molecular diagnostic tool for active TB detection amplifies DNA from both live and dead 
mycobacteria in sputum samples (Weyer et al., 2012; Lawn et al., 2013). 
Increased concentrations of interleukin 18 (IL-18) and high expression of chemokine ( c-c motif) 
receptor (CCR7) accompanied by low expression of Bcl2 in RNA extracted from blood samples have 
been shown to differentiate persons who developed active TB from controls (Sutherland et al., 2011). 
Increased IL-18 concentrations in patients with active TB have been reported to be in direct 
proportion with the extent of the disease (Yamada et al., 2000). In TB and other inflammatory 
diseases, IL-18 induces T-cell activation, as well as interferon Y while CC chemokines are 
responsible for the recruitment of lymphocytes to the site of infection which is an essential step in 
immune response to M. tuberculosis infection (Wallis et al. , 2013). Some of the pathogen-specific TB 
biomarkers that have been previously identified include the early secretory antigen target 6 (ESAT 6), 
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antigen 85 complex (Ag85) and the M tuberculosis cell wall component, lipoarabinomannan (LAM) 
(Mukundan et al., 2012). 
ESAT6 is used as a biomarker for TB diagnosis using the interferon-Y release assay (Zwerling et al., 
2012). Talaat et al. (2010) developed immunoassays for the rapid detection of ESAT6 antibodies in 
TB patients which were associated with 97.6% sensitivity and 75% specificity. The production of 
antibodies to ESAT6 has also been reported to be a sensitive strategy for early bovine TB infection 
detection (Koo et al., 2005). Antibodies to the Ag85 complex have been shown to be produced in the 
blood of patients with central nervous system TB (Kashyap et al., 2001; Miki et al., 2004) and 
tuberculous meningitis (Kashyap et al., 2005). The direct detection of LAM, a lipoglycan component 
of M. tuberculosis cell wall, for the diagnosis of TB was evaluated by Reither et al. (2009) using a 
plate-based sandwich ELISA (enzyme-linked immunosorbent assay) immunoassay in blood samples 
of patients with pulmonary TB in Tanzania. They demonstrated the assay's sensitivity of 87.8% and a 
specificity of 66.7% and 62% in women and patients with HN co-infection, respectively, when 
compared to the sputum-smear microscopy. Adhesins, due to their surface localisation, may serve as 
potential biomarkers and novel targets for antimicrobial drugs. 
1.11. Bacterial Adhesins 
Binding of pathogenic bacteria to any mucosal surfaces is an essential step in the pathogenesis of 
many infections. To achieve this, bacteria make use of an array of adhesins displayed at their cell 
surfaces and these highly specific proteins are usually expressed at different stages during infection 
(Kumar et al., 2013). Interactions between infecting bacteria and host cells are aided by specialized 
microbial adhesins that mediate attachment to the surface of host cells (Figure 5). Adhesins allow 
pathogenic bacteria to attach to host cells and resist physical removal from the surface and that leads 
to invasion and induction of signalling cascades such as cytokine production (Niemann et al., 2004 ). 
Microbial adhesins usually appear as polymeric organelle structures as well as non-organelle 
structures attached to the surface of bacterial cells as monomers or oligomers (Klemm and Schembri, 
2000). 
Adhesion Invasion ProMeration 
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Figure 5: The role of bacterial adhesins in the infection of host cells. Adhesins located at the surface 
of the bacteria bind to host cell ligands which leads to the invasion of the macrophage. Once they've 
invaded, bacteria survive and replicate within the host cells (Govender et al., 2014). 
1.11.1 M. tuberculosis Adhesins 
M. tuberculosis expresses a number of different essential adhesins (Figure 6) such as heparin-binding 
hemagglutinin adhesin (HBHA), Apa, malate synthase (MS), 19 kDa, laminin binding protein (LBP) 
(Kumar et al., 2013) andM tuberculosis pili (MTP) (Alteri et al., 2007). HBHA is a major adhesin of 
epithelial cells (Pethe et al., 2001) involved in bacterial attachment to lungs and in extrapulmonary 
dissemination of the bacteria (Pethe et al., 2001; Kumar et al, 2013). MTP are curli pili that bind 
laminin and are produced during the infection of host cells (Alteri et al., 2007). LBP is involved in 
cytoadherence through the recognition of laminin (Kumar et al., 2013). M tuberculosis also expresses 
essential enzymes such as CPN60.2, glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and MS 
that are encoded by cpn60.2, gap and glcB respectively and are believed to have potential adhesion 
function (Dumke et al., 2011) . In 2010, Hickey et al reported the involvement of CPN60.2 in bacterial 
attachment to macrophages. M. tuberculosis adheres to and invades animal and human epithelial cells 
and macrophages via various entry mechanisms (Alteri et al., 2007). Inadequate knowledge has been 
generated with regards to host-microbe interactions as well as a series of events that take place before 
bacteria invade and replicate in host cells. The specific bacterial adhesins involved in the interplay are 
also largely unknown (Alteri et al., 2007). 
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Figure 6: M. tuberculosis adhesin-mediated host-pathogen interaction. Adhesins use specialized 
pathways to initiate host interaction and colonization. (Modified from Kumar et al., 2013; by 
Govender et al., 2014). 
1.12. Bacterial Pili 
Adhesins, including pili, are the first bacterial point of contact with host cells, where they help with 
the overcoming of net repulsive forces on the two cell surfaces (Proft and Baker, 2009). Pili are 
composed of major repeated pilin subunits as well as a tip-associated adhesin unit. A variety of genes 
are needed for pili biogenesis and these encode proteins involved in membrane translocation, major 
pilin subunit, chaperone, minor subunit, prepilin peptidase, channel-forming proteins and nucleotide-
binding proteins (Strom and Lory, 1993; Thanassi et al., 1998; Klemm and Schembri, 2000). They're 
viewed as bacterial virulence factors due to their key role in pathogenesis and therefore, they are 
important targets for vaccine and drug development (Finlay and Falkow, 1997). Pili are associated 
with biological activities such as colonization of mucosa! surfaces, agglutination of human and animal 
red blood cells and bacterial adherence (Finlay and Falkow, 1997). 
Gram-negative bacteria possess pili that are formed as a result of non-covalent homopolymerization 
of pilins (Proft and Baker, 2009). Moreover, pilins may be added to the fiber where they function as 
adhesion molecules to host cells. Pili found in Gram-negative bacteria are mainly associated with 
DNA uptake, phage transduction, biofilm formation, as well as twitching which is a special form of 
bacterial movement (Proft and Baker, 2009). In contrast, Gram-positive pili are formed by covalent 
polymerization of pilin subunits which is attributed to the sortase enzyme (Telford et al., 2006). The 
addition of minor pilins to the fiber leads to host cell colonization by Gram-positive bacteria (Proft 
and Baker, 2009). Gram-negative bacteria produce different types of pili in S pili, P pili, Type I pili, 
Type N pili and Curli Pili (Telford et al., 2006; Proft and Baker, 2009). Type N pili are 
differentiated into Type Na and Type Nb pili (Proft and Baker, 2008). Gram-positive bacteria 
produce Spa pili, PI-1 pilus, PI-2 pilus, Type I pili and Type II pili, Type N pili and Curli Pili 
(Telford et al., 2006; Alteri et al., 2007; Proft and Baker, 2009). 
1.12.1. Type IV Pili 
Type N pili are found in Pseudomonas aerugi,nosa, Neisseria gonorrhoeae, Vibrio cholera, 
Aeromonas hydrophila (Giron et al., 1991; Strom and Lory, 1993; Giron et al., 1994) and in 
Legionella pneumophila. They're involved in virulence and intracellular infection of human 
macrophages (Liles et al., 1998; Stone and Abu, 1998), as well as biofilm formation and 
development, DNA transformation, colonization of host tissues and bacterial aggregation (Strom and 
Lory, 1993; Bieber et al., 1998). Type N pili have hydrophobic amino terminus and a signal peptide. 
They appear under the electron microscope as long filaments with rope-like structures. 
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1.12.2. Curli Pili 
Pathogens such as Escherichia coli and Salmonella typhimurium (Romling et al., 1998), Gram-
positive pathogens Group B Streptococcus and Corynebacterium diptheriae (Lauer et al., 2005) 
possess curli pili, with the latter being closely related to Mycobacterium in terms of phylogeny and the 
complexity of the cell wall (De Sousa-D'Auria et al., 2003). Curli pili are associated with 
colonization of abiotic surfaces, internalization into epithelial cells and persistence in poultry 
infections (Kluftinger et al., 1989; Chen and Dubnau, 2003). They're also involved in the induction of 
cytokine activation during human sepsis (Bian et al., 2000) and development of biofilms by binding to 
host proteins such as plasminogen, major histocompatibility complex class I (MHC n molecules and 
extracellular matrix (ECM) proteins (Olsen et al., 1989; Bian et al., 2000; Olsen et al., 2002). 
1.12.2.1. M. tuberculosis curli pili (MTP) 
Using negative staining and transmission electron microscopy (TEM), Alteri et al. (2007) provided 
genetic, biochemical and ultrastructural data which revealed that M tuberculosis produces two types 
of pili, Type IV and curli pili, during human infection. M tuberculosis curli pili (MTP) encoded by 
the mtp gene (Rv3312A), are highly sticky, aggregative and insoluble fibers that bind laminin (Alteri 
et al., 2007). 
The role of MTP as adhesive structures was supported by their data which showed that purified MTP 
has an ability to bind to laminin, a component of the extracellular matrix. To determine whether the 
ability of MTP to bind to laminin was attributed to the mtp gene, M. tuberculosis mutants lacking the 
mtp gene were generated and their binding affinity was compared to that of a wild type strain. Their 
findings showed that the mutants demonstrated a 40-fold reduction in laminin-binding capacity when 
compared to the wild type strain, suggesting that MTP mediates adhesion to the extracellular matrix. 
M. tuberculosis produces molecules that are recognized as antigens by the host during infection and 
this leads to the production of antibodies which their presence is a powerful indicator that an antigen 
was produced during a natural infection (Alteri et al., 2007). To determine if M tuberculosis produces 
MTP during infection, Alteri et al. (2007) applied immunofluorescence (IF) microscopy in sera from 
TB patients to detect the presence of anti-MTP IgG antibodies. Their findings showed that among the 
individuals that were tested, 60% produced a positive MTP-IgG reaction. 
Recent studies have suggested that MTP may be a major adhesin and invasin of macrophages 
(Ramsugit and Pillay, 2014) and epithelial cells (Ramsugit et al., 2016). Ramsugit et al. (2016) 
revealed that MTP-deficient strain of M. tuberculosis demonstrated a significant reduction in its 
ability to adhere to and invade A549 pulmonary epithelial cells when compared to the wild type strain 
while the complementation of the gene restored its functions to the wild type levels (Figure 7). 
Furthermore, the wild type and mtp-mutant strains induced similar concentrations of cytokine and 
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chemokines in A549 epithelial cells, suggesting that MTP does not largely influence the cytokine 
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Figure 7: The role of MTP in adhesion (A) to and invasion (B) of A549 alveolar epithelial cells. 
A549 epithelial cells were infected with the wild type, mtp-mutant and mtp-complemented strains of 
M. tuberculosis for 1 hour (adhesion) and 2 hours (invasion). (Ramsugit et al., 2016). 
In addition to epithelial cells, loss of MTP was also shown to decrease adhesion to, and invasion of 
THP-1 monocyte derived macrophages (Figure 8), whilst complementation of MTP resulted in an 
increased expression of the mtp gene compared to the wild type (Ramsugit and Pillay, 2014). The role 
of MTP in M. tuberculosis biofilm formation has been identified and documented (Ramsugit et al., 
2013), indicating that they may present an important target for the development of therapeutics. 
Naidoo et al. (2014) investigated the role of MTP as a diagnostic biomarker. BLAST analysis on 
publically available genome databases and sequencing was performed in order to detect the presence 
of the mtp gene in M. tuberculosis complex strains (MTBC). The mtp gene and its encoded protein 
product, MTP, were found to be unique to MTBC strains and their absence in non-tuberculous 









































Figure 8: The role of MTP in adhe i.on (A) to and invasion (B) of macrophages. THP-1 macrophages 
were infected with the wild type, mtp-mutant and mtp-complemented strains of M tuberculosis for 1 
hour (adhesion) and 2 hours (invasion). (Ramsugit et al., 2014). 
1.13. Whole Transcriptome Analysis 
Advances in M. tuberculosis genetics have allowed for the development of existing techniques and 
establishment of new techniques that are aimed at improving the analyses of in vivo and in vitro M 
tuberculosis gene expression. Techniques such as subtractive hybridisation, real-time polymerase 
chain reaction (RT-PCR) and DNA microarray technology have been employed in studying events 
that take place at gene expression level in host tissues after they've been infected with M. tuberculosis 
(Waddell and Butcher, 2007). 
1.13.1. Real time PCR 
Before the development of hybridization and sequence-based techniques that are used in gene 
expression studies nowadays, RT-PCR had emerged as a robust method of choice due to its ability to 
detect and amplify small amounts of nucleic acids (Valasek and Repa, 2005). In gene expression 
studies, RT-PCR has been widely applied in order to accurately and rapidly detects changes in the 
expression levels of specific genes in a very short space of time (Deepak et al., 2007). 
RT-PCR differs from conventional PCR as it allows for the monitoring of DNA while it's being 
amplified and this allows researchers to be able to determine the amount of starting DNA in the 
sample before amplification (Valasek and Repa, 2005). RT-PCR amplifies specific nucleic acid 
sequences in a sample and monitors the progress of DNA amplification using fluorescent dyes such as 
ethidium bromide and SYBR green (Deepak et al., 2007). One of major restrictions for conventional 
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PCR is that it can only use DNA as a template whereas RT-PCR makes use of a reverse transcriptase 
enzyme which has an ability to generate complementary DNA ( cDNA) from an RNA template 
(Valasek and Repa, 2005). RT-PCR limitations include susceptibility to inhibition by components 
(haemoglobin and urea) of certain biological samples such as haemoglobin and urea. RT-PCR cannot 
be used to target the entire genome of a particular species and as a result of recent technological 
advancements it has been limited to being used as a confirmatory tool for RNA sequencing and 
microarray findings (Deepak et al., 2007). 
1.13.2. DNA Microarray Analysis 
DNA microarray technology has been one of the most widely used techniques for the investigation of 
transcriptional profiles on a genome-wide level in recent years (Talaat et al., 2002). This technology 
has been largely applied in studies that are aimed at developing new antimicrobial drugs and vaccines 
by exploring transcription profiles of infectious pathogens on a genome-wide level (Talaat et al., 
2002). Microarray technology makes use of nucleic acids probes that are bound to glass slides 
(Mantione et al., 2014). Target sequences (fluorescently labelled) are hybridized to the probes, 
scanned and the images are converted to signal intensities followed by data analysis with an aid of a 
software specific to the platform in use (Mantione et al., 2014). Microarray technology is high 
throughput and has been widely used in whole genome studies in the past due to its reliability and 
inexpensive nature (Wang, 2009). In the past ten years, microarray analysis has become easier owing 
to small raw data files, user friendliness of the software packages as well as protocols that are 
comparable across all platforms and are universally applicable (Mantione et al., 2014). 
According to Kendall et al. (2004), microarrays are seen as tools that are used to generate hypothesis 
and can also be used to sort and compare data from different studies which then can be analysed in 
detail using more definitive methods. Microarrays have proven to be more useful when applied in 
gene expression studies based on the hypothesis that changes in gene expressions levels are 
biologically significant e.g. it could be predicted that M tuberculosis genes that are up-regulated after 
macrophage infection are more likely to be essential for intracellular survival of the pathogen 
(Kendall et al., 2004). Waddell (2004) further stated that monitoring of whole genome expression will 
allow a precise definition of differentially expressed genes that are involved in host-pathogen 
interactions. Microarray technology has been applied in gene expression studies that are aimed at 
investigating M tuberculosis response to different environmental conditions such as low iron 
(Rodriguez et al., 2002), carbon starvation (Betts et al., 2002), heat shock (Stewart et al., 2002) and 
hypoxia (Park et al., 2003). Ryndak et al. (2015) investigated the transcriptional profile of M. 
tuberculosis replicating in A549 alveolar epithelial cells using microarray technology. Up-regulated 
genes were associated with tryptophan synthesis and increased virulence, whereas, down-regulated 
genes were associated with stress and heat shock response and DosR regulon (Ryndak et al., 2015). 
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However, this technique has a number of limitations that include spotting efficiency, transcript 
representation, high levels of background noise owing to cross-hydridization, low hybridization 
reproducibility (Talaat et al., 2002) as well as limited range of detection (Mantione et al., 2014). 
1.13.3. RNA-Sequencing (RNA-Seq) 
RNA sequencing is a recently developed deep sequencing-dependent approach for transcriptome 
profiling that provides more precise measurements of gene expression levels than any other method 
(Wang et al., 2009). The technique involves fragmenting of RNA which is followed by reverse 
transcription and labelling with adapter sequences (Mantione et al., 2014). Unlike microarray 
methods, sequence-based approaches are high throughput, provide precise gene expression levels and 
they can directly determine the cDNA sequence (Wang et al., 2009). RNA sequencing remains 
advantageous over existing approaches and is believed to have a huge potential to revolutionize the 
manner in which trascriptomes are analysed (Nagalakshmi et al., 2010). It has an ability to achieve a 
much higher resolution of genes that are differentially expressed and has a low limit of detection 
when compared to microarrays (Zhao et al., 2014). Chen et al. (2015) reported that recent 
developments in high-throughput next generation sequencing technologies has gradually promoted 
RNA-seq to be the main method of choice for whole transcriptome profiling and analysis. 
RNA-seq can carry out transcription fragment sequencing in an unbiased manner (Wang et al., 2009). 
Unlike microarrays, RNA-seq has an ability to detect novel sequences in a genome and has a very low 
background noise (Wang et al., 2009). RNA-seq has its own limitations which include working with 
large data files and therefore, making data analysis, management, sharing and storage difficult 
(Trapnell et al., 2012). RNA-seq data analysis requires extensive experience and bioinformatics skills 
essential for the handling of big data files (Trapnell et al., 2012). Numerous data analysis methods can 
be applied but there's no standard protocol (Trapnell et al., 2012). Technological and software 
developments will allow for the mitigation of the complicated nature of RNA-seq data analysis. It is 
believed that its high cost will eventually drop over time, therefore the method has a bright future and 
a huge role to play in gene expression studies and bioinformatic data collection (Mantione et al., 
2014). 
Some work that has been done on RNA sequencing for M tuberculosis was by Zhang et al. (2014). 
They evaluated the potential of microRNAs as biomarkers for TB where they applied Solexa 
sequencing to examine their expression in the serum of patients with active disease, individuals with 
latent TB and healthy individuals with or without BCG inoculation. The microRNA expression profile 
obtained showed 24 and 6 microRNAs up and down regulated respectively in patients with active TB, 
75 and 11 in patients with latent TB and 134 differentially expressed between BCG inoculated and 
un-inoculated individuals. Mvubu et al. (2016) demonstrated, using RNA-sequencing, that different 
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strains of M tuberculosis induce differential gene expression and strain-specific molecular signatures 
in A549 alveolar epithelial cells. 
Rienksma et al. (2015) applied dual RNA sequencing with an aim of getting an insight into 
transcriptional adaptation of attenuated M. tuberculosis surrogate M bovis Bacillus Calmette-Guerin 
(M bovis BCG) in a monocyte derived THP-1 cell line. Microbial enrichment and specific ribosomal 
RNA depletion was used to simultaneously analyze host and pathogen transcriptional responses. Their 
findings showed that genes involved in aspartate metabolism, cholesterol biosynthesis and recycling 
of mycolic acids were up-regulated. RNA sequencing has been employed to investigate bovine 
macrophage response to M. bovis infection in vitro over a 24-hour period (Nalpas et al., 2013). Their 
gene ontology analysis of differentially expressed genes showed an induction of cell signalling, 
apoptotic and immune response genes. The number of differentially expressed genes identified using 
RNA-sequencing was greater (2584 vs 2015) than the number of genes they had identified in their 
previous study using microarray technology. Furthermore, their data revealed a greater range of 
detection and gene transcript quantification for RNA-sequenced compared to microarrays. 
Before RNA-seq, it was assumed that much greater fractions of Drosophila melanogaster (Bertone et 
al., 2004) and the human genome were transcribed and a large number of distinct isoforms had been 
found for many genes belonging to these species. However, the starts and ends of exons and 
transcripts had not been fully explored and resolved therefore, high resolution and sensitivity of RNA-
seq has helped reveal many novel genes, transcribed regions as well as more splicing isoforms of 
known genes (Bertone et al., 2004). Chen et al. (2015) used RNA-sequencing to elucidate the 
response of lung epithelial cells infected with Aspergillus fumigatus. Using a cut off fold change of 
1.5 or greater, they found 302 (66%) up-regulated and 157 (34%) down-regulated genes. Their gene 
ontology enrichment analysis showed that up-regulated genes were associated with immune response, 
chemotaxis, cell activation and response to bacterium whereas down-regulated genes were mainly 
enriched for skeletal system development, hemopoiesis, ion transport and immune response. 
1.14. Infection Models 
Numerous gene expression studies aimed at better understanding the survival mechanisms of M. 
tuberculosis inside the host cells have been conducted and published since its first sequencing in 1998 
(Kendall et al., 2004; Waddell and Butcher, 2007). The data that has been generated from these 
expression studies needs to be utilized in order to understand the mechanisms that are employed by M 
tuberculosis during infection establishment and evasion of the host immune response (Ward et al., 
2010). One of the challenges facing TB research is the difficulty of working with the bacteria, an 
extremely low infectious dose and the severity of the disease which means that research must always 
be carried out within specialized facilities (Ward et al., 2010). 
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The lengthy doubling time of M tuberculosis coupled with its lipid-rich cell wall makes extraction of 
bacterial RNA difficult and this is one of the main reasons why many gene expression studies have 
been conducted in vitro (Ward et al., 2010). These in vitro models have been developed in a way that 
mimics the intracellular conditions (low oxygen levels, low nutrients, low pH and heat shock) that M. 
tuberculosis faces inside the host cells (Fontan et al., 2008). However, in vitro infection models are 
unable to fully mimic the conditions found in an in vivo system. It is very unlikely for these models to 
represent normal surroundings of intracellular pathogens and form granulomas which are very much 
involved in the control of M tuberculosis infection (Ward et al., 2010). Despite all these limitations, 
in vitro models have been widely used in gene expression studies using macrophages and epithelial 
cells (Fontan et al., 2008). 
Genes coding for bacterial survival, intracellular replication and virulence are the main targets for 
novel antimicrobial drugs, especially those located at cell surfaces and are easily accessible to 
antibiotics (Triccas and Gicquel, 2000). Analysis of complete gene expression profiles in mouse 
macrophages showed that M. tuberculosis exposed to a fatty acid rich and iron deficient environment 
could damage the cell envelope, as well as bacterial DNA (Schnappinger, 2003). Biological 
experiments conducted in broth culture simulating conditions in the macrophage environment 
(hypoxia, starvation and low pH) in lung mouse models, mouse macrophages and cell line models 
have generated much information on M. tuberculosis gene expression (Fontan et al., 2008). 
Transcriptional profiles of M tuberculosis infecting human macrophages and macrophage-like THP-1 
cell lines provided evidence that this organism regulated genes involved in the evasion of the immune 
system (Fontan et al., 2008). 
Cell lines such as the THP-1 and A549 have been widely used in studies involving the analyses of 
interactions that take place between mycobacteria and human host cells (Fontan et al., 2008). The use 
of cell lines overcomes difficulties presented by human primary cells e.g. genetic variability and other 
donor to donor differences (Iona et al., 2012). The treatment of THP-1 cells with phorbol-myristate 
acetate (PMA) differentiates them into mature macrophages, allowing interactions such as bacterial 
uptake, replication and survival to be analysed (Fontan et al., 2008). Most infection studies have 
focused on macrophage models, despite the presence of a greater proportion of epithelial cells 
compared to the former in the human lung alveolus (Iona et al., 2012). Thus, it is likely that epithelial 
cells may be the first cells to encounter M. tuberculosis adhesins rather than macrophages. Epithelial 
cells have also been shown to play an important role in inducing host immune response upon infection 
with M tuberculosis (Castro-Garza et al., 2002). 
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1.15. Gene Knockout Experiments 
Emerging gene knockout/knock.in technologies are promising future prospects for the evaluation of 
the effects of single gene inactivation on the M. tuberculosis transcriptome during infection. These 
should increase our understanding of natural M. tuberculosis infections and contribute towards the 
development of novel antimicrobial drugs and vaccines (Waddell and Butcher, 2007). A swift 
development of functional genomics for pathogenic mycobacteria is needed in order to generate an 
understanding on genetic basis for their persistence and virulence in the host (Bardarov et al., 2002). 
Gene transfer strategies have been widely used for fast growing bacteria such as Mycobacterium 
smegmatis, however, the construction of strains with defined single or multiple mutations has always 
been difficult with slow-growing mycobacteria (Bardarov et al., 2002). The usage of DNA fragments 
as allelic exchange substrates for homologous recombination has been successfully applied for gene 
disruption in slow-growing M. tuberculosis and M. bovis BCG (Azad et al., 1996). 
A 'suicide'vector approach and a two-step selection method have both been reported to be successful 
in achieving allelic exchange in both slow and fast- growing mycobacteria, however, these methods 
lack an efficient homologous recombination and the 'suicide' vector method is dependent upon the 
delivery of allelic exchange substrates by electroporation (Bardarov et al., 2002). These limitations 
would be overcome by a highly efficient, reproducible and phage-based genetic method called 
specialized transduction, which is used to generate targeted gene deletions in both fast and slow-
growing mycobacteria by allelic exchange with the aid of in vitro-generated specialized transducing 
mycobacteriophages (Bardarov et al., 2002). 
Gene knockout studies have been largely and successfully used to elucidate gene function in M. 
tuberculosis. The effectiveness and reproducibility of the specialized transduction method were 
demonstrated by the generation of seven auxotrophic M. smegmatis strains, three M. bovis BCG 
substrains and three M. tuberculosis strains (Bardarov et al., 2002). The use of phagemids in gene 
replacement experiments with M. tuberculosis H37Rv was found to increase levels of homologous 
recombination and decrease illegitimate recombination. This method has also been successfully used 
to generate gene mutations in the M. tuberculosis H37Rv, Erdman and Beijing F2 strains (Lamrabet et 
al., 2012). Previous studies have indicated that genes coding for M. tuberculosis virulence and 
survival are up regulated during the infection of host cells (Triccas and Gicquel, 2000). 
Like any other intracellular pathogen, M. tuberculosis induces a cascade of genes in response to 
different conditions it encounters inside the host cells (Fontan et al., 2008). However, it is not clear 
whether the expression of one gene influences expression of other genes or not. M. tuberculosis genes 
that have been studied by gene knockout include lysA, nadBC, panC, panCD, leuCD, Rv3291c 
Rv0867c (Bardarov et al., 2002) and rp/(Russell-Goldman et al., 2007). Russell-Goldman et al. used 
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specialized transduction to construct single (rpfA and rpfB) and double knockouts (rpfAB) of the rpf 
gene. The rpf gene codes for resuscitation-promoting factor (Rpf), a peptidoglycan hydrolase 
responsible for the reactivation of bacteria (Russell-Goldman et al., 2007). They demonstrated that the 
deletion of rpfB impaired the reactivation of M tuberculosis in mouse model. Since M tuberculosis 
encodes five Rpf paralogues, a series of rpf double knockouts were generated and results showed a 
further increased impairment of bacterial reactivation. 
1.16. Significance of Study 
The role of adhesin genes, in particular mtp, in M. tuberculosis and host gene regulation is of special 
interest. Adhesins, including MTP, are regarded as one of the most important virulence factors in 
pathogenic bacteria (Klemm and Schembri, 2000). Therefore, this study would contribute to a better 
understanding of the role of MTP in TB pathogenesis and further elucidate its potential as a biomarker 
for the development of new drugs and vaccines. Furthermore, whole transcriptome studies during 
infection of host cells could prove to be important in the identification of other novel biomarkers 
(Klemm and Schembri, 2000). This study will evaluate the effects of mtp in gene regulation of A549 
pulmonary epithelial cells using a M tuberculosis mtp mutant and full transcriptome RNA 
sequencmg. 
1.17. Aims and Objectives 
Aim: 
To perform full transcriptome analysis by RNA sequencing to determine host gene regulation in A549 
epithelial cells infected with an mtp knockout mutant. 
Objectives: 
To achieve the above aim, the following objectives were established: 
1. To infect A549 cells (human alveolar basal epithelial cells) with mtp gene knockout mutant and 
wild type strains of M tuberculosis V9124. 
2. To extract RNA from A549 epithelial cells infected with mtp gene knockout mutant and wild type 
strains of M. tuberculosis V9124. 
3. To perform RNA sequencing for the whole transcriptome analysis of infected A549 cells. 
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CHAPTER2:METHODOLOGY 
2.1. Ethics Clearance 
The study was approved by the Biomedical Research Ethics Committee, University of KwaZulu-Natal 
(BREC Reference Number: BE280/14). 
2.2. Strains and Growth Conditions 
M. tuberculosis wild type V9124, a clinical isolate of the Fl5/LAM4/KZN (KZN) family, isolated 
from the Tugela Ferry (KwaZulu-Natal, South Africa) and its l:lmtp mutant were obtained from the 
culture collection of Medical Microbiology and Infection Control (University of KwaZulu-Natal). The 
mtp mutant was constructed in V9124 by specialized transduction with allelic exchange substrate 
(Ramsugit et al., 2013). Strains were cultured in 10 mL Middlebrook 7H9 broth (Difeo) containing 
10% Oleate-Albumin-Dextrose-Catalase (OADC; Becton Dickinson), 0.5% glycerol (Sigma), and 
0.25% Tween-80 (Sigma) at 37°C with shaking for 7 days to an OD6oo = 1.0, equivalent to 
approximately lx108 colony forming units (CFU)/mL (Larsen et al., 2007). 
2.3. Revival of Frozen A549 Epithelial Cell Stocks 
A volume of 1 mL of thawed A549 epithelial cells (ATCC CCL-185) was added to 20 mL of ElO 
medium [Eagle's Minimal Essential Media (EMEM) with L-glutamine (Lonza) and 10% Fetal Bovine 
Serum (FBS; Biowest)] in a 250 mL tissue culture flask (Lasec) and incubated for 5 days in a 
humidified 37°C incubator with 5% C02. The cells were washed with phosphate buffered saline 
(PBS; Oxoid) and fresh ElO media was added after 24 hours in order to get rid of the DMSO, non-
adherent and dead cells. The cells were incubated in a humidified 37°C incubator with 5% C02 for 7 
days. 
2.3.1. Recovery of A549 Epithelial Cells 
Confluent A549 epithelial cells were washed thrice with 10 mL of PBS. A volume of 2 mL of trypsin 
(Biowest) was added and cells were incubated in a humidified 37°C incubator with 5% C02 for 5 
minutes, allowing them to detach (by tapping flask vigorously). Trypsinization was stopped by adding 
2 mL FBS against the cell layer. Detached A549 cells were removed and placed in a 15 mL tube. 
2.3.2. Enumeration of A549 Epithelial Cells 
A cell count was performed using the Trypan Blue Exclusion Assay. A coverslip was placed on the 
hemocytometer and an aliquot of the cell suspension (20 µL cells with 20 µL trypan blue) was applied 
by capillary action. The hemocytometer was placed under the microscope for the viewing of the cells 
over a grid. Cells in four big squares (each containing 16 small squares) were viewed and counted. 
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Only the viable, white cells were counted, as the blue cells were dead. The total number of cells/mL 
was obtained by multiplying the average number of cells in the four big squares by a dilution factor of 
2 and 104 in order to determine the number of cells/mL in a diluted sample. 
2.3.3. Seeding of A549 Epithelial Cells 
A volume of 5x105cells/mL was added to 7 x 250 mL tissue culture flasks each containing 20 mL of 
ElO medium. Flasks were incubated to confluency in a humidified 37°C incubator with 5% C02 for 5 
days. Thereafter, the spent medium was discarded, cells were washed once with 10 mL of PBS and 20 
mL of fresh El 0 medium was added to each flask. Cells were now ready for infection. A cell count 
was performed using one flask in order to determine the number of A549 epithelial cells to be 
infected. 
2.4. Construction of mtp-knockout mutant and mtp-complemented strains 
The construction of the mtp-knockout mutant and mtp-complemented strains was carried out as 
described in Ramsugit et al. (2013). An allelic exchange substrate (AES) designed to replace the mtp 
gene with a hygromycin-resistance (hygR)-sacB cassette was donated by W. R. Jacobs, Jr., from the 
Albert Einstein College of Medicine (AECOM). Briefly, upstream and downstream arms were 
digested with BstAPI andVan91I, respectively, and cloned into Van91I-digested pYUB1471 vector 
arms. The resulting AES was digested with Paci and ligated with Paci-digested phAE159, in vitro 
packaged using a MaxPlax packaging extract (Epicentre Biotechnologies), and transduced in the E. 
coli HBlOl strain (Invitrogen Life Technologies) for construction of shuttle phasmids. The phasmids 
were electroporated into Mycobacterium smegmatis mc2155 (gift from W. R. Jacobs, Jr.) and 
incubated at 30°C for phage propagation. Specialized transduction of the M tuberculosis V9124 wild-
type strain was performed. A 188-bp region of the mtp gene was deleted. Genomic DNA of the 
deletion mutant was isolated and screened using PCR. The mtp gene is not operonic, the deletion was 
in frame and confirmed by sequencing as part of a previous study (Ramsugit et al., 2013). For 
complementation, the mtp gene was cloned into the pMV261 vector. The sequence was then amplified 
using PCR and its products were sequenced for confirmation. 
2.5. Infection of A549 Epithelial Cells 
The cells were transferred to the BSL2+ laboratory and all the subsequent steps were performed in the 
class II safety cabinet. A volume of 5 mL of each of the M. tuberculosis V9124 wild type and mtp 
knockout mutant cultures (OD6oo = 1) was pelleted at 2,000g for 20 minutes. Supematants were 
discarded and pellets re-suspended in 50 mL ElO by vortexing. An OD600 was measured in order to 
determine the number of organisms, as loss of cells can occur during centrifugation and to bring all 
cultures to an OD6oo = 0.1. A549 epithelial cells were then infected in triplicate with M. tuberculosis 
V9124 wild type strain and mtp knockout mutant strain at a multiplicity of infection (MOI) of 10:1 
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and incubated at 37°C with 5% C02, and 95% humidity for 1, 2, 4 and 24 hours respectively. 
Experiments were repeated thrice for all the time intervals. Uninfected A549 cells were used as a 
control. 
2.5.1. Determination of Colony Forming UnitslmL 
Serial dilutions of the initial bacterial suspensions were plated out in order to determine an accurate 
bacterial count. Eppendorf tubes (Merck) were used to make 10-5 dilutions by transferring 100 µL 
suspensions into 900 µl 7H9 broth. Aliquots of 100 µL were plated onto 7Hl I agar plates in triplicate, 
sealed in C02 permeable plastic bags and incubated at 37°C for 3 weeks, after which the colony 
counts were read. Colony forming units (CFU)/mL were calculated according to the formula: Number 
of Bacterial Colonies Counted x Dilution FactorNolume Plated. Similarly, CFU/mL was determined 
at each interval post infection, after epithelial cells were lysed with buffer RL T to release invaded 
bacilli. 
2.6. Extraction of RNA from Infected A549 Epithelial Cells 
The spent medium was removed after incubation and the cells were washed thrice with I 0 mL of PBS 
in order to remove non-adherent cells. Cells were trypsinized using 2 mL of trypsin and incubated for 
5 minutes in a humidified 37°C incubator with 5% C02. A volume of 2 mL FBS was added to stop 
trypsinization. Cells were transferred to 15 mL tubes and centrifuged at 300 x g for 5 minutes. The 
supernatant was discarded and RNA was extracted from the pellet using the RNeasy Mini Kit 
(RNeasy Mini Handbook, 4th Edition, 2012, Qiagen). Briefly, 350 µL of lysis buffer RLT (Qiagen) 
with 3.5 µL ofbeta-mercaptoethanol (Sigma) was added to lyse epithelial cells. Cells were transferred 
to 2 mL eppendorf tubes (Merck) and passed I 0 times through a blunt 20 gauge needle (Becton 
Dickinson) fitted to an RNase-free syringe (Becton Dickinson). A volume of 350 µL 70% ethanol 
(Sigma) was added and the lysate was transferred to an RNeasy spin column (Qiagen) placed in a 2 
mL collection tube (Qiagen). The lysate was centrifuged for 15 seconds at 12 000 rpm, the flow-
through was discarded and 700 µL of buffer RWl (Qiagen) was added to the spin column. After 
centrifugation for 15 seconds at 12 000 rpm, the flow-through was discarded and 500 µL of buffer 
RPE (Qiagen) was added to the spin column. This wash step was repeated with 500 µL of buffer RPE. 
The lysate was centrifuged for 2 minutes at 12 000 rpm and the flow-through was discarded. The spin 
column was placed in a new 2 mL collection tube and centrifuged at 12 000 rpm for 1 minute. The 
spin column was placed in a new 1.5 mL collection tube (Qiagen), 30 µL of RNase-free water 
(Qiagen) was added and centrifuged for 1 minute in order to elute RNA. RNA extracted from 
uninfected A549 cells was used as a control. 
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2.7. Assessment of RNA Quality 
RNA concentration and integrity m each sample were determined using a Nanodrop 2000 
spectrophotometer (Thermofisher Scientific) and a 3-(N-Morpholino) propanesulfonic acid (MOPS, 
Sigma) gel respectively. The RNA quality was also assessed at Johns Hopkins University Deep 
Sequencing and Microarray Core Facility using the Agilent 2100 BioAnaylzer machine with an RNA 
Integrity (RIN) value of 7 being used as a cut-off point. 
2.8. cDNA Library Preparation and Sequencing 
A total of 6 x RNA samples (2 x control samples, 2 x samples each A549 cells infected with M 
tuberculosis V9124 wild type strain and mtp-knockout mutant strain) from the 4 hour post-infection 
interval were couriered on dry ice to Johns Hopkins University Deep Sequencing and Microarray 
Core Facility. The 4 hour time interval was chosen because the aim of this study was to determine the 
role of MTP in initiating host-pathogen interactions by adhering to and invading epithelial cells and 
inducing early innate immune response against M. tuberculosis upon invasion through the induction 
of changes on host gene regulation. A cDNA library was prepared using the Illumina ScriptSeq 
Complete Gold kit for Epidemiology according to manufacturer's instructions 
(http://www.illumina.com/products/scriptseq-epidemiology .html). Briefly, 225 µL of magnetic beads 
were added to an RNase-free tube and placed on a magnetic stand for 1 minute at room temperature 
(RT). Beads were washed with 225 µL of RNase-free water and place on a magnetic stand. The wash 
step was repeated after which beads were re-suspended in 65 µL of the Re-suspension Solution. For 
rRNA removal, each sample was treated with 40 µL of rRNA Removal Solution, incubated for 10 
minutes at 68°C and then for 5 minutes at RT. 
Magnetic beads were added and the mixture was vortexed and incubated at RT for 5 minutes and then 
at 50°C for another 5 minutes. The mixture was placed on a magnetic stand and the supernatant 
(rRNA-free sample) was transferred to an RNase-free tube and precipitated with ethanol. For RNA 
fragmentation, 1 µL of RNA Fragmentation Solution was added and the mixture was incubated at 
85°C for 5 minutes in a thermocycler and then placed on ice. For cDNA synthesis, a cDNA master 
mix of 4 µL was added to the mixture, mixed by pipetting and incubated at 25°C for 5 minutes 
followed by 42°C for 20 minutes and cooling to 37°C. A Finishing Solution of 1 µL was added and 
the mixture was incubated at 37°C for 10 minutes followed by 95°C for 3 minutes and cooling to 
25°C. A volume of 8 µL of a Terminal Tagging master mix (for adaptor tagging) was added and the 
mixture was incubated at 25°C for 15 minutes followed by 3 minutes at.95°C and cooling to 4 °C. The 
mixture was eluted in 22.5 µL of Agencourt AMPure or Qiagen MinElute solution for cDNA 
purification. cDNA was amplified with Polymerase Chain Reaction (PCR) and the library was 
purified using AMPure purification. Sequencing was carried out using the Illumina HiSeq 2000 
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Sequencing Software System (www.illumina.com/support). Samples were pooled and sequenced in 
duplicate as paired-ends with a length of 100 base pairs and coverage of25-35 million per sample. 
2.9. Bioinformatics Analysis 
2.9.1. Read Quality Control, Mapping and Generation of Gene Expression Profiles 
The quality of the reads was assessed using the FastQC toolkit (v. 0.10.1). All reads had a quality 
score of 34/38. Sequencing reads were then mapped to the Homo sapiens UCSC hg38 reference 
genome (support.illumina.com/sequencing/sequencing_software/igenome.html) using TopHat (v. 
2.1.0) (Trapnell et al., 2012). All samples had an overall mapping rate> 69% (Table 2). Differential 
gene expression profiles and fold changes between infected and uninfected epithelial cells were 
generated with Cuffdiff(v. 2.2.1) (Trapnell et al., 2012). 
2.9.2 Global Gene Expression and Statistical Analysis 
An FPKM pairwise scatter plot comparison was performed in order to investigate global gene 
expression profiles of uninfected A549 epithelial cells relative to A549 cells infected with the mutant 
and wild type strain. The significance of differences between the two strains was analysed by one-way 
analysis of variance (ANOVA) using SPSS 24.0 statistical software. p < 0.05 was considered 
significant. 
2.9.3. Differential Gene Expression, Gene Ontology and Ingenuity Pathway Analysis 
Differentially expressed genes were filtered using a cut-off point of 2 and a Venn diagram was created 
using VENNY (http://bioinfogp.cnb.csic.es/tools/venny old/venny.php) software in order to 
determine the number of genes that were shared as well as genes that were unique to A549 epithelial 
cells infected with the wild type or mtp-knockout mutant strain. Gene Ontology analysis was 
performed using the Comparative Toxicogenomics Database (http://ctdbase.org/) . Biological 
processes, molecular functions and cellular components were enriched using a corrected p-value of 
0.05 and a highest Gene Ontology level of 3. Heat maps of gene expression profiles in A549 epithelial 
cells infected with M. tuberculosis V9124 wild type and mtp-knockout strains were created using a 
MultiExperiment Viewer (MeV, v. 4.9.0) software. Differentially expressed genes were used to 
investigate canonical pathways, networks and transcriptional factors induced by the M tuberculosis 
V9124 wild type and mtp-knockout strains in A549 epithelial cells. Changes in canonical pathways, 
network and transcription factor enrichment were investigated with Ingenuity Pathway Analysis (IP A 
v. 01-07, Ingenuity Systems, USA). 
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CHAPTER3:RESULTS 
3.1. Infection of A549 Epithelial Cells 
A549 epithelial cells were infected in triplicate with wild type and mtp-knockout mutant strains of M. 
tuberculosis V9124 at an MOI of 10 for 4 hours. The initial bacterial inoculum for the wild type and 
mtp-knockout mutant strain was l.03xl04 CFU/mL and l.028xl04 CFU/mL respectively (Figure 9). 
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Figure 9: Initial bacterial inoculum used to infect A549 epithelial cells. A549 epithelial cells were 
infected with the wild type and mtp knockout mutant strain. CFU/ml was determined in order to 
obtain the initial bacterial inoculum for each strain before incubation. 
After 4 hours of incubation, epithelial cells were washed thrice with PBS and cells were lysed with 
Triton.X-100. The lysate was plated out for CFU/ml enumeration in order to determine the number of 
M tuberculosis cells that were able to invade epithelial cells. The number of invaded bacteria 
observed in A549 epithelial cells infected with the wild type strain (2.47x103 CFU/ml) did not differ 














Figure 10: Number of bacteria infecting A549 epithelial cells. After 4 hours of incubation, infected 
epithelial cells were washed 3 times with PBS and lysed with TritonX-100. CFU/ml was determined 
in order to obtain the final number of bacteria that were able to invade epithelial cells. 
3.2. RNA Concentration and Integrity 
Table 1: NanoDrop and BioAnalyzer (Johns Hopkins University, Deep Sequencing and Microarray 
Core) results of RNA extracted from uninfected A549 epithelial cells (control) and A549 epithelial 
cells infected with M tuberculosis wild type and mtp-mutant strains. 
Number Sample Concentration 260/280 260/230 RNA Integrity 
(ng/µl) (RIN) 
; 1 Uninfected 957.94 2.10 2.08 10 
2 Uninfected 1045.18 2.11 2.20 10 
' 3 Wild t}rpe-infected 1397.15 2.09 2.07 9.7 .. 
- ·- . . . ~ ·· - " · '- . · -
4 Wild type-infected 1402.05 2.09 2.11 10 
1 s· ... -- ~-.--~- · . --· . 2.23 10 Wild type-infected 1733.81 2.09 
6 Mutant-infected 1303.61 2.10 2.13 9.8 
7 Mutant-infected 1612.83 2.08 2.23 10 
8 Mutant-infected 1594.78 2.08 2.21 9.8 
The yield, purity and integrity of RNA extracted from infected and uninfected A549 epithelial cells 
were all high as shown by the concentrations, 260/280 and 260/230 ratios and RNA Integrity (RIN) 
values (Table 1). RNA samples 1, 2, 4, 5, 7 and 8 were sent out for sequencing. A cut off value of 2.0 
was used for 260/280 and 260/230 ratios while 7.0 was used for RIN. 
After RNA extraction, a MOPs gel (Figure 11) and virtual gel (Figure 12) (Johns Hopkins, University 
Deep Sequencing and Microarray Core) were performed in order to further confirm the integrity of 
the RNA samples. 
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Figure 11: MOPS gels showing 28S and 18S bands of RNA extracted from infected and uninfected 
A549 epithelial cells. X-axis: A: Lanes: l(RNA extracted from uninfected A549 cells), 3 (RNA 
extracted from uninfected A549 cells), 5 (RNA extracted from A549 cells infected with the wild type 
strain), and 6 (RNA extracted from A549 cells infected with the wild type strain) and B: Lanes: 
l(RNA extracted from A549 cells infected with mtp-knockout strain) and 3 (RNA extracted from 







25 - ---------· 
l 2 3 4 5 6 8 
< 28$ 
<-1_8s _ __. 
Figure 12: A virtual gel image showing 28S and 18S bands of RNA extracted from infected and 
uninfected A549 epithelial cells. X-axis: Lane L: Bands of a molecular weight marker (bp). Lanes 1-
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8: RNA samples shown in Table 1. Y-axis: Molecular weight size. RNA samples formed 18S and 
28S rRNA bands at 1800kb and 3800kb, respectively. 
3.3. RNA-Sequencing Read Quality Control 
RNA samples were sequenced using the HiSeq Illumina 2000 platform as paired ends at a length of 
100 bp per end. Quality control was performed on sequenced reads using the FastQC software and all 
samples had a high read quality score (Figure 13). In all samples, the first 5 reads had a mean 
(indicated by the red line) quality score of 33-34 whereas reads 6-100 had a mean quality score of 38. 
A B 
Quelltyscores across all bases (SanQer / IU.urnlna 1.9 encoding) 
~ ~J'H~'"RIHHfflll ~ , , 



























1 2 3 4 5 6 7 B 9 15-19 25-29 35-39 45·49 55-59 65-69 75-79 95-89 95-99 D 1 2 3 4 5 6 7 8 9 15-19 25·29 3.5-3!il 415·49 55-59 65-69 75-79 SS-89 95-99 
Position In read (,bp) Postlon In re5d (bp) 
c 
1 :Z J t ' 6 7 D I 1 ~19 ~-lS 'n-:tl U-.1 ~ 6'!1{11 ?!i:·'lt l~ .. t f'fi 
,OK1UI., l'llM Ult:i) 
D 
Qv*Y tc:orn KrDS1 _. basu ls.nQer / llk.Pn11 1.9 .ncodin;I 




































l 2 i 4 5 0 7 B 9 15·lll 25-29 3~351 45-49 ~.:;o t15.ff 75-79 BS4111 D5-011 
Pa11t1onlnr*Cld(bpl 
G 




-bd: --'...L...b-...1..--l...L' 1-± :± '.J J I I _I 
...L ...L J_J_j_ lj_l 




































I I I l±.U l::::cLLl±f - [ J _J_J ±±±l i[...L..l..l: J_J_...L. ~...LJ..: - ...L.J_ J__J_J_ -

























i 2 i " s s 1 a 11 is-1D 2S·29 35.3g 45-4P ss.sg 65-6D 75.7; es.a; Ps-Q!li 0 i 2 J " s e 1 e 11 is-19 15.29 35.39 45-49 '''" ~oa 15.79 es.gg 95~9 
P!OltiUon in read (bp) Pattlai In nt&d (bpJ 
Figure 13: Read quality scores of left and right end of RNA sequences of samples: RNA extracted 
from uninfected A549 cells (A and B), RNA extracted from uninfected A549 cells (C and D), RNA 
extracted from A549 cells infected with the wild type strain (E and F), RNA extracted from A549 
cells infected with the wild type strain (G and H), RNA extracted from A549 cells infected with mtp-
knockout mutant strain (I and J) and RNA extracted from A549 cells infected with mtp-knockout 
mutant strain (Kand L). X-axis: Position in Read. Y-axis: Read Quality Score Rating. RNA samples 
were sequenced using the Hi Seq Illumina 2000 platform as paired ends at a length of 100 bp per end. 
The red lines and blue line represent the mean quality and median value, respectively. Green: Good 
quality reads. Orange: Average quality reads. Red: Poor quality reads. 
3.4. Mapping of RNA-Sequencing Reads 
After quality control on sample sequences, reads were mapped to a human reference genome (Homo 
sapiens UCSC hg38) using TopHat where an overall read mapping rate for each sample was 
generated. The read mapping rate of RNA from A549 epithelial cells ranged from 69.4 to 84%, with 
the highest from A549 epithelial cells infected with the wild type strain and lowest from uninfected 
A549 epithelial cells (Table 2). 
Table 2: Overall read mapping rate for all the RNA samples that were sequenced. 






















3.5. Global Gene Expression Analysis 
The role of MTP on gene regulation in A549 human alveolar epithelial cells was investigated using 
genome-wide whole transcriptome analysis on A549 epithelial cells infected with the wild type and 
mtp-knockout mutant strain at 4 hours post M. tuberculosis infection, relative to uninfected A549 
cells. After the alignment of sequenced reads to the human reference genome (Homo sapiens UCSC 
hg38) using TopHat, Cuffdiffwas used to generate gene expression profiles of differentially expressed 
genes (DEGs) induced in A549 epithelial cells in response to infection with the two M tuberculosis 
strains. An overview of transcript abundance, expressed as Fragments Per Kilobase of Transcript per 
Million Mapped Reads (FPKM), induced in infected A549 epithelial cells, relative to uninfected cells, 
was investigated using pairwise scatter plots. 
An FPKM pairwise scatter plot comparison was performed in order to investigate global gene 
expression profiles of uninfected A549 epithelial cells relative to A549 cells infected with the mutant 
(Figure 14) and wild type strain (Figure 15). The majority of genes induced in A549 cells as a result 
of the mtp-mutant infection had FPKM values in the region of 0-500 in relation to uninfected cells. 
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Figure 14: FPKM pairwise comparison of global gene expression profiles of A549 cells infected with 
the mtp-mutant strain relative to uninfected A549 epithelial cells. X and Y axis represent FPKM 
values of genes induced in A549 epithelial cells in response to infection with the mtp-mutant strain, 
relative to uninfected cells. Genes with similar FPKM values are closer to the line of regression. 
Genes below the regression line had low FPKM values while genes above had high FPKM values. 
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Unlike in the mutant infection, a majority of genes induced in A549 epithelial cells as a result of the 
wild type infection had higher FPKM values, ranging from 0-1000, in relation to uninfected cells 






















Figure 15: FPKM pairwise comparison of global gene expression profiles of A549 cells infected with 
the wild type strain relative to uninfected A549 epithelial cells. X and Y axis represent FPKM values 
of genes induced in A549 epithelial cells in response to infection with the wild type strain, relative to 
uninfected cells. Genes with similar FPKM values are closer to the line of regression. Genes below 
the regression line had low FPKM values while genes above had high FPKM values. 
3.6. M. tuberculosis Induces Differential Gene Expression in Epithelial Cells 
After the generation of gene expression profiles in A549 epithelial cells infected with the mtp-mutant 
and wild type strains of M tuberculosis, relative to uninfected A549 epithelial cells, significantly 
differentially expressed genes (SDEGs) were obtained by filtering DEGs based on significance and 
using a Log2 fold change cut-off point of 2. The wild type strain induced a total of 917 SDEGs 
compared to 725 by the mtp-knockout mutant strain in A549 epithelial cells, relative to uninfected 
cells. A total of 307 and 115 SDEGs were exclusively induced by the wild type and mtp-knockout 
mutant strain, respectively, while 610 genes were induced by both strains (Figure 16). The induction 
of a high number of total and unique SDEGs by the wild type strain compared to the mtp-mutant 








Figure 16: Significantly differentially expressed genes induced by the wild type and mtp-knockout 
mutant strains of M tuberculosis in A549 pulmonary epithelial cells, relative to uninfected cells. The 
wild type strain induced the expression of a high number of total and unique genes in A549 epithelial 
cells compared to the mtp-mutant strain. 
The number of up and down-regulated SDEGs in all 5 conditions is shown in Table 3. The wild type 
strain induced a higher number of down-regulated compared to up-regulated SDEGs. In contrast, the 
mtp-knockout mutant strain induced a high number of up-regulated compared to down-regulated 
genes. The number of up-regulated genes was higher than down-regulated genes amongst those that 
were shared by both strains, whilst genes that were uniquely induced by both strains were mostly 
down-regulated genes. 
Table 3: Significantly differentially expressed genes that were up- and down-regulated by both strains 
in A549 epithelial cells, relative to uninfected cells. 
ALL WT ALL 
MUTANT 
l Genes 917 725 
Up-regulated 434 387 
Down-regulated 483 338 
ALL WT: All wild type-induced SDEGs. 










UNIQUE WT: All SDEGs exclusively induced by the wild type strain. 





All top 10 most up-regulated SDEGs were shared by both strains except for FXYD2 and NEK2 which 
were exclusive to the wild type and mtp-mutant strain, respectively (Table 4). The fold change of the 
top 10 most up-regulated genes by the wild type and mutant strains ranged from 6.30766 (FXYD2) to 
8.18454 (TKJ) and 6.46674 (KIAAOJ 01) to 8.33365 (TKJ), respectively. All most up-regulated genes 
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that were shared by both strains were highly induced by the mutant strain compared to the wild type, 
except for KIAAOJ 01. 
The top 10 down-regulated genes were exclusively induced by each strain except for AMTN and 
SCG5, which were induced by both strains. Both these genes were highly down-regulated by the wild 
type strain compared to the mutant strain. The top 10 most down-regulated genes by the wild type 
strain ranged from a fold change of -5.83867(RPLPOP2) to -8.12269 (UQCRHL) while those down-
regulated by the mutant strain ranged from -5.15085 (FAM49A) to -5 .84926 (CDJ63Ll). All top 10 
most down-regulated genes were highly suppressed by the wild type strain compared to the mutant 
strain. 
Table 4: The 10 most up- and down-regulated genes induced by the wild type and mtp-mutant strain 
in A549 pulmonary epithelial cells. 
Wild type mtp-mutant 
Up-regulated Gene Fold Change Gene Fold Change 
TKJ 8.18454 TKJ 8.33365 
MKl67 7.59066 MK167 8.25201 
BIRC5 7.41559 MYBL2 7.75614 
MYBL2 7.25921 BIRC5 7.6842 
MCMJO 7.1523 MCMJO 7.5441 
DLGAP5 7.14504 DLGAP5 7.42044 
KIAAOJOJ 6.6899 UBE2C 6.94315 
UBE2C 6.63154 CCNB2 6.68863 
CCNB2 6.38028 NEK2 6.65515 
FXYD2 6.30766 KIAAOJOJ 6.46674 
Down-'regulated Gene Fold Change Gene Fold Change 
UQCRHL -8.12269 CDJ63Ll -5.84926 
KRT34 -7.09732 AMTN -5.79149 
... ·-
RPL13AP5 -6.59157 PAPPA2 -5.68869 
AMTN -6.44063 scd5 ~5~66398 
PIP SL -6.38781 DMGDH -5.42477 
FAM45B -6.26196 FABP6 _5j4328 
ATP6VOD2 -6.25275 PTPRR -5.30236 
RPS18P9 ~6.15522 LCPJ -5.26313 
SCG5 -6.06841 ILJRLJ -5.19347 
RPLPOP2 -5.83867 FAM49A -5.15085 
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3. 7. Gene Ontology Analysis 
The generation of gene expression profiles using Cuffdiff in A549 epithelial cells infected with the 
wild type and mtp-mutant strains of M. tuberculosis, in relation to uninfected cells, yielded 917 and 
725 SDEGs, respectively. A total of 610 SDEGs were commonly induced by both strains while 307 
and 115 genes were exclusively induced by the wild type and mtp-mutant strain, respectively. SDEGs 
were then enriched for biological functions using the Comparative Toxicogenomics Database with a 
correctedp-value of 0.05 and a highest Gene Ontology level of 3. 
3.7.1. Gene Expression Profiles of Common SDEGs Induced by M. tuberculosis 
A total of 610 SDEGs were commonly induced by both wild type and mtp-mutant strains in A549 
pulmonary epithelial cells, relative to uninfected cells. These genes were then enriched for biological 
functions according to their level of expression (up- or down-regulated) using gene ontology analysis. 
Up-regulated genes were enriched for DNA replication, cell cycle and cell division, regulation of cell-
to-cell adhesion, as well as host immune response functions such as complement activation, signal 
transduction and response to wounding and antigen presentation via MHC class II (Table 5). Some 
up-regulated genes were involved in multiple biological functions e.g. C3 and C4BPA were associated 
with complement activation and signal transduction and response to wounding, HLA-DMB: antigen 
presentation and regulation of cell-to-cell adhesion, CCL2: signal transduction and response to 
wounding and regulation of cell-to-cell adhesion, CDKJ: signal transduction and response to 
wounding and DNA replication, BRCAJ: DNA replication and cell cycle and cell division. 
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Table 5: Biological functions associated with up-regulated SDEGs induced by both strains in A549 
pulmonary epithelial cells, relative to uninfected cells. 
Gene Ontology Functions Genes 
Up-regulated Complement Activation 
Antigen Presentation via MHC 
Class II 
Signal Transduction and 
Response to Wounding 
DNA Replication 
Cell Cycle and Cell Division 
Regulation of Cell-to-Cell 
Adhesion 
C3, C4BPA, CFB, CFH, CF!, SUSD4, VTN 
APJM2, HLA-DMB, KIFJJ, KIF15, KIF18A, 
KIF23, KIF2C, KIF4A 
ANGPTJ, ARRBJ, C3, C4BPA, CCL2, CCNBJ, 
CDKJ, CFB, CFD, CFH, CF! 
BRCAJ, CDC25A, CDC45, CDC6, CDKJ, 
CDTJ, CHEKJ, CLSPN 
ANLN, ASPM, AURKA, AXIN2, BIRC5, 
BRCAJ, BRJPJ, BUBJ, BUBJB, CASC5, 
CCNA2, CCNBJ, CCNB2, CCND3 
CCL2, CD24, EGR3, FGA, FGB, FGG, HESJ, 
HLA-DMB, MAP3K8, MYB, NR4A3, SOX2 
Down-regulated genes were associated with cell communication, enzyme binding, regulation of 
cellular metabolic processes as well as host response-related functions such as the cell surface 
receptor signalling pathway and cell and lymphocyte activation (Table 6). Some down-regulated 
genes were also associated with multiple biological functions e.g. ACKR3: cell communication, cell 
surface receptor signalling pathway and regulation of cellular metabolic processes, ARHGEF2: cell 
communication, enzyme binding, cell surface receptor signalling pathway and regulation of cellular 
metabolic processes, CCBEJ: cell communication, enzyme binding and cell surface receptor 
signalling pathway, CD8A: cell communication, cell surface receptor signalling pathway, lymphocyte 
and cell activation and enzyme binding, ILi 2A and IL6: cell communication, cell surface receptor 
signalling pathway, lymphocyte and cell activation and regulation of cellular metabolic processes, 
CD274: cell surface receptor signalling pathway and lymphocyte and cell activation, IRF4: cell 
surface receptor signalling pathway, lymphocyte and cell activation and regulation of cellular 
metabolic processes. 
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Table 6: Biological functions associated with down-regulated SDEGs induced by both strains in 
A549 pulmonary epithelial cells, relative to uninfected cells. 
Down-regulated 
Gene Ontology Functions 
Cell Communication 
Enzyme Binding 
Cell Surface Receptor 
Signalling Pathway 
Lymphocyte Activation and 
Cell Activation 
Genes 
ACKR3, ARHGAP25, ARHGDIB, 
ARHGEF2, EMF, CCBE/, 
CD8A, Ill 2A, IL6 
ARHGEF2, BHLHE41, BRSKI, 
CACNBI, CACNB2, CCBEI, 
CD8A, CSTA 
ACKR3, AKAP3, ARHGEF2, 
CCBEJ, CD274, CD8A, DACTI, 
FOXLI, GOS2, GBPJ, GDF6, 
GREMJ, HDAC9, IGFBPJ, 
ILl2A, IL6, IRF4 
CD274, CD8A, DOCK2, HDAC9, 
ILi 2A, IL20RB, IL6, IRF4, LAT, 
LCPI 
To display gene expression profiles of the SDEGs that were induced by both strains in A549 epithelial 
cells, expression levels of top 50 most up- and down-regulated genes were investigated using a heat 
map (Figure 17). Amongst top 100 genes, both strains significantly up-regulated DNA replication 
genes such as CDC45 and CDC6 while cell surface receptors such as CD22 and CDI 63Ll were 
down-regulated. HISTIH genes (HISTIH2AL, HISTIH3B and HISTIH3C) were up-regulated by both 
strains while PTP genes (PTPRH, PTPRO and PTPRR) were down-regulated. SERPIN genes were 
differentially expressed with SERPINB3 and SERPINB4 down-regulated and SERPINA6 up-regulated 
by both strains. A differential expression by both strains was also observed with FAM genes where 
F AMJ 11 B and F AM64A were up-regulated while F AM49A was down-regulated. TKJ, MK/67, BIRC5, 
MYBL2, MCMJO and DLGAP5 were the most up-regulated genes by both strains whereas AMTN, 






































































































Figure 17: Gene expression profiles of top 50 (out of 345) up-regulated and top 50 (out of 265) 
down-regulated genes induced by both strains in A549 pulmonary epithelial cells at 4 hr post-
infection, relative to uninfected cells. Sequenced reads were mapped to the reference genome using 
TopHat. Cuffdiff of the RNA-sequencing Tuxedo pipeline was used to identify differentially 
expressed genes between uninfected and infected epithelial cells. 
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3.7.2. Strain-specific SDEG Expression Profiles 
One hundred and fifteen (115) SDEGs were uniquely induced by the mtp-mutant strain in A549 
alveolar epithelial cells, with 43 and 72 genes up- and down-regulated, respectively. Our gene 
ontology analysis showed that up-regulated genes were enriched for biological functions such as 
protein refolding, cellular response to heat, programmed cell death as well as positive regulation of 
tumor necrosis factor-mediated pathways (Table 7). Heat shock proteins HSPAJA and HSPAJB were 
associated with all the above-mentioned functions whereas HSPA6 was only involved in protein 
refolding and cellular response to stress and heat. DDIAS, EEF2K and PRDX2 were all associated 
with programmed cell death and cellular response to stress and heat. 
Table 7: Biological functions associated with up-regulated SDEGs induced by the mtp-mutant strain 
in A549 pulmonary epithelial cells, relative to uninfected cells. 
> Up-regulated 
Gene Ontology Functions 
Protein Refolding 
Cellular Response to Stress and Heat 
Programmed Cell Death 
Positive Regulation of Tumor Necrosis 
Factor-Mediated Pathways 
Genes 
HSPAJA, HSPAJB, HSPA2, 
HSPA6 
CHAFJA, DD/AS, EEF2K, 
HISTJH4D, HSPAJA, HSPAJB, 
HSPA6, KLFJO, KLF2, PRDX2, 
RECQL4, SNAIJ 
APLPJ, DDIAS, EEF2K, HSPAJA, 
HSPAJB, !DJ, LMNBJ, PRDX2, 
SNAIJ, TNS4 
HSPAJA, HSPAJB 
Down-regulated genes induced by the mtp-mutant strain in A549 epithelial cells were enriched for 
cellular processes, binding and ion binding (Table 8). ABAT, ADRB2, AIFM3, ALOX5AP, BBSJ 0, 
CDK14, CYP27Bl, EIF4A2 and HACR2 were associated with all the above mentioned biological 
functions whereas ACOT4, BBC3, FYB and GSAP were associated with cellular processes and 
binding. HFMJ was involved in both cellular processes and ion binding while ADAM32, ADAMTS6 
and AMY2B were associated with binding and ion binding 
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Table 8: Biological functions associated with down-regulated SDEGs induced by the mtp-mutant 
strain in A549 pulmonary epithelial cells, relative to uninfected cells. 
Gene Ontology Functions 




ABAT, ACOT4, ADRB2, 
AIFM3, ALOX5AP, BBC3, 
BBSJ 0, CDK14, CYP27Bl, 
EIF4A2, FYB, GSAP, HAVCR2, 
HES6, HFMJ, HOXD8, HYDIN 
ABAT, ACOT4, ADAM32, 
ADAMTS6, ADRB2, AIFM3, 
ALOX5AP, AMY2B, BBC3, 
BBSJO, CDK14, CYP27BJ, 
EIF4A2, FYB, GSAP, HAVCR2 
ABAT, ADAM32, ADAMTS6, 
ADRB2, AIFM3, ALOX5AP, 
AMY2B, BBSJ 0, CDKJ 4, 
CYP27Bl, EIF4A2, HAVCR2, 
HFMJ, MATJA, NELL2 
The wild type strain uniquely induced 307 SDEGs in A549 alveolar epithelial cells, with 89 and 218 
genes up- and down-regulated respectively. Up-regulated genes were enriched for cell 
communication, signal transduction, response to lipids and cellular response to chemical stimulus 
(Table 9). All genes involved in cell communication, except for ANG, LDHA, MAPRE2 and NMU, 
were also associated with signal transduction. Moreover, ADCY5 was involved in all above mentioned 
biological functions while ADM and EDNJ also played a role in signal transduction and response to 
lipids. ERBB3, IFITM3 and IL6ST were associated with cell communication, signal transduction and 
cellular response to chemical stimulus while NR2FI, NR5A2, PTGER2 and UCP2 were involved in 
response to lipids and cellular response to chemical stimulus. 
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Table 9: Biological functions associated with up-regulated SDEGs induced by the wild type strain in 
A549 pulmonary epithelial cells, relative to uninfected cells. 
Up-regulated 
Gene Ontology Functions 
Cell Communication 
Signal Transduction 
Response to Lipids 
Genes 
ABCC9, ADCY5, ADM, ANG, 
ANXA4, BCAM, CALY, 
CAMKJ, EDNJ, EPHA6, 
ERBB3, GSG2, HISTJH4B, 
HISTJH4C, IFITM3, IGF2, 
IL6ST, LDHA, MAPRE2, NMU 
ABCC9, ADCY5, ADM, 
ANXA4, BCAM, CALY, 
CAMKJ, EDNJ, EPHA6, 
ERBB3, GSG2, HISTJ H4B, 
HISTJ H4C, IFITM3, IGF2, 
IL6ST 
ADCY5, ADM, APOH, AQP3, 
EDNJ, IGF2, LDHA, NR2Fl, 
NR5A2,PTGER2, UCP2 
Cellular Response to Chemical ACY3, ADCY5, ADH6, CXCL3, 
Stimulus EDNJ, ERBB3, IFITM3, IGF2, 
IL6ST, MTJF, NR2Fl, NR5A2, 
POU5Fl, PTGER2, STOXJ, 
TBXASJ, UCP2, ff/NT4 
Down-regulated genes induced by the wild type strain in A549 epithelial cells were enriched for cell 
communication, signal transduction, cell differentiation and regulation of biosynthetic processes 
(Table 10). It is important to note that down-regulated genes that were enriched for cell 
communication and signal transduction were completely different from the up-regulated genes that 
were enriched for the same functions. However, the trend that was observed in up-regulated genes 
associated with these functions was also observed with down-regulated genes where all genes 
associated with cell communication, except for CNTN4 and IL23A, were also involved in signal 
transduction. Moreover, EDA2R was associated with cell differentiation and regulation of biosynthetic 
processes while ADRA2C, CDKNJC, CNT4 and DNER were involved in C((ll differentiation. CRLFJ 
was involved in cell communication and regulation of biosynthetic processes while FRMD6 was only 
associated with cell differentiation and regulation ofbiosynthetic processes. 
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Table 10: Biological functions associated with down-regulated SDEGs induced by the wild type 
strain in A549 pulmonary epithelial cells, relative to uninfected cells. 
· Down-regulated 






ADGRDJ, ADRA2C, AKAP12, 
ARHGEF4, ASIC2, ATP6VOD2, 
CALCB, CAPN3, CDKL2, 
CDKNIC, CLEC2D, CNTN4, 
COL16Al, CRLFJ, DISPJ, 
DNER,ECA11,EDA2R,IL23A 
ADGRDJ, ADRA2C, AKAP 12, 
ARHGEF4, ASIC2, ATP6VOD2, 
CALCB, CAPN3, CDKL2, 
CDKNJC, CLEC2D, COLl6AI , 
CRLFI, DISPJ, DNER, ECA11, 
EDA2R 
ADRA2C, ARID5A, CAPN3, 
CATSPER3, CCDC85B, CDH4, 
CDKNIC, CEBPG, CNTN4, 
CRTACI, DNER, EDA2R, 
FHL2, FRA1D6, GAB2 
CRLFI, EDA2R, FOXDI, 
FRA1D6, HES7, HEYi, 
KCNA1Al, KRT34, LAA1B3, 
NKX2-5, PGF, PODXL 
The role of MTP in enrichment of canonical pathways was investigated with know ledge-based IP A 
using datasets of SDEGs induced in A549 alveolar epithelial cells by the wild type strain, mtp-
knockout mutant strain, shared SDEGs as well as SDEGs that were unique to the wild type strain and 
mtp-knockout mutant strain (Table 11 ). 
The wild type strain enriched the highest number of canonical pathways compared to the mtp-mutant 
strain. SDEGs that were exclusively induced by the wild type also enriched the highest number of 
canonical pathways than those that were unique to the mtp-mutant strain (Table 11 ). These findings 
suggest that MTP affects gene regulation of A549 epithelial cells through differential gene expression. 
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A pathway for Cell Cycle Control of Chromosomal Replication was the highest enriched pathway by 
both strains. The Role of IL-17 A in Arthritis and LPS/IL-1 Mediated Inhibition of RXR Function 
pathways were the lowest enriched pathways by the wild type and mtp-mutant strain, respectively. 
Table 11: Canonical pathways enriched by SDEGs induced by wild type and mtp-knockout mutant 











ALL WT: All wild type-induced SDEGs. 










UNIQUE WT: All SDEGs exclusively induced by the wild type strain. 
UNIQUE MUTANT: All SDEGs exclusively induced by the mutant strain. 
3.8.1. Canonical Pathway Analysis 
A total of 27 canonical pathways were enriched by both strains while 3 and 17 pathways were 









Figure 18: The number of canonical pathways that were enriched by significantly differentially 
expressed genes induced by the wild type and mtp-knockout mutant strains of M. tuberculosis in 
A549 epithelial cells after 4 hours of infection. A three-way Venn diagram was created using the 
VENNY software. 
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3.8.2. Pathways Commonly Induced by the wild type and mutant strain 
A total of 27 canonical pathways were enriched by both wild type and mtp-mutant strain in A549 
epithelial cells, relative to uninfected cells (Figure 19). Our canonical pathways analysis showed that 
23 of the 27 shared pathways were highly enriched by the mtp-mutant strain compared to the wild 
type strain (Figure 19). The wild type strain highly enriched 4 pathways (FXR/RXR Activation, 
Ethanol Degradation II, Ethanol Degradation N and LPS/IL-1 Mediated Inhibition of RXR Function) 
compared to the mtp-mutant strain and all these were low ranking pathways. All top 10 high ranking 
pathways were highly enriched by the mtp-mutant strain, compared to the wild type strain. Both 
strains induced pathways involved in normal cellular processes and early host immune response. The 
Cell Cycle Control of Chromosomal Replication pathway was the highest enriched pathway by both 
strains, however, this pathway was highly enriched by the mutant strain. LPS/IL-1 Mediated 
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Ethanol Degradation IV 
Ethanol Degradation II 
IL-17A Signaling in Fibroblasts 
Differential Regulation of Cytokine Production 
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Role of BRCAl in DNA Damage Response 
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GADD45 Signaling 
Role of Tissue Factor in Cancer 
Intrinsic Prothrombin Activation Pathway 
Role of CHK Proteins in Cell Cycle Checkpoint Control 
Complement System 




Cell Cycle: G2/M DNA Damage Checkpoint Regulation 
Extrinsic Prothrombin Activation Pathway 
Mitotic Role of Polo-like Kinase 
Cell Cycle Control of Chromosomal Replication 
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Figure 19: A total of 27 canonical pathways were enriched by both wild type and mtp-knockout 
mutant strains in A549 epithelial cells. -log p values (which correlate with the level of enrichment) 
were used to compare the enrichment of these pathways in each infection condition. A total of 23 
canonical pathways were highly enriched by the mtp-mutant strain compared to the wild type strain. 
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3.8.3. Host Immune Response-related Pathways Commonly Induced by both strains 
Both strains enriched pathways associated with host immune response e.g. Acute Phase Response 
Signaling, Complement System and Differential Regulation of Cytokine production in Macrophages 
and T helper cells. 
Genes involved in Acute Phase Response Signaling Pathway were differentially induced by both 
strains (Figure 20). However, this pathway was highly enriched by the mtp-mutant strain compared to 
the wild type. Both strains up-regulatedPL3K/P85 complex, SERPINAJ, CP, SERPINA3, FGG, FGB, 
FGA, LBP, CFB, AMBP, CFOS and C4BP genes while IL-6 was the only down-regulated gene. The 
wild type strain exclusively up-regulated GP 130 and APOH genes whereas C3, which is very 
essential for the acute phase response, was exclusively up-regulated by the mtp-mutant strain. 
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Figure 20: Acute Phase Response Signaling Pathway. Canonical pathways enriched by wild type 
strain (A) and mtp- mutant strain (B). SDEGs associated with this pathway are displayed with red and 
green which indicate up- and down-regulated genes. The brighter the red or green colour, the more 
up- and down-regulated the gene in A549 epithelial cells, relative to uninfected cells. Genes shaded in 
white are part of the knowledge-based IPA software and were not expressed in our datasets. 
In addition to the Acute Phase Response Signalling Pathway, the Complement System Pathway, 
especially the alternate pathway, was more highly enriched by the mtp-mutant compared to the wild 
type strain in A549 epithelial cells, relative to uninfected cells (Figure 21). Both strains up-regulated 
C4BP, BF, IF, HFJ, DF, BFA and BFB genes while the mtp-mutant strain exclusively up-regulated 
C3, C3A and C3B genes. 
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Figure 21 : Complement System Pathway. Canonical pathways enriched by wild type strain (A) and 
mtp- mutant strain (B). SDEGs associated with this pathway are displayed with red and green which 
indicate up- and down-regulated genes. The brighter the red or green colour, the more up- and down-
regulated the gene in A549 epithelial cells, relative to unifected cells. Genes shaded in white are part 
of the knowledge-based IP A software and were not expressed in our datasets. 
3.8.4 M. tuberculosis Exclusively Enriches Three Pathways in the Absence of MTP 
In addition to canonical pathways that were commonly enriched by both strains in A549 epithelial 
cells, pathways that were exclusively enriched by the mtp-mutant strain were investigated further. In 
the absence of the mtp gene, only three pathways were uniquely enriched by the mtp-mutant strain 
(Figure 18). Amongst the three, p53 Signaling Pathway was the highest enriched pathway in mtp-
mutant-infected A549 epithelial cells while Glioma Invasiveness Signalling Pathway was the lowest 
enriched pathway (Figure 22). 
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Deoxyribonucleotides 
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Figure 22: Pathways that were exclusively enriched by the mtp-knockout mutant strain in infected 
A549 epithelial cells. MTP did not have any effect on these pathways. 
A majority of genes involved in the p53 Signalling Pathway were up-regulated (Figure 23). PUMA 
molecules and HDAC9 and Slug transcription regulators were down-regulated whereas PL3K, CHKI , 
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Figure 23: p53 Signaling Pathway. Canonical pathway exclusively enriched by mtp- mutant strain. 
SDEGs and molecules associated with this pathway are displayed with red and green which indicate 
up- and down-regulated genes. The brighter the red or green colour, the more up- and down-regulated 
the gene in A549 epithelial cells, relative to unifected cells. Genes shaded in white are part of the 
knowledge-based IP A software and were not expressed in our datasets. The legend on the right hand 
side shows different molecules displayed on the pathway. 
The pathway for Salvage Pathways of Pyrimidine Deoxyribonucleotides was the second highest 
exclusively enriched pathway by the mtp-mutant strain (Figure 24). Deoxycytidine dearninase and 
thyrnidine kinase were the only up-regulated molecules in this pathway while other molecules were 
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Figure 24: Salvage Pathways of Pyrimidine Deoxyribonucleotides Pathway. Canonical pathway 
exclusively enriched by mtp- mutant strain. Molecules associated with this pathway are displayed 
with red and green which indicate up- and down-regulated genes. The brighter the red or green colour, 
the more up- and down-regulated the molecule in A549 epithelial cells, relative to unifected cells. 
Molecules shaded in white are part of the knowledge-based IP A software and were not expressed in 
our datasets. 
The Glioma Invasiveness Signalling pathway was the lowest exclusively enriched canonical pathway 
by the mtp-mutant strain in A549 epithelial cells (Figure 25). Cell surface receptors involved in this 
pathway were both up- and down-regulated, with the ITG receptor being down-regulated and the 
RHAMM receptor being up-regulated. Vibronectin, RHO and PL3K molecules were up-regulated, 
whereas, the expression of other genes and molecules associated with this pathway were not induced 
by the mtp-mutant strain in A549 epithelial cells. 
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Figure 25: Glioma Invasiveness Signalling Pathway. Canonical pathway exclusively enriched by 
mtp- mutant strain. Molecules associated with this pathway are displayed with red and green which 
indicate up- and down-regulated genes. The brighter the red or green colour, the more up- and down-
regulated the gene in A549 epithelial cells, relative to unifected cells. Molecules shaded in white are 
part of the knowledge-based IPA software and were not expressed in our datasets. The legend on the 
right hand side shows different molecules displayed on the pathway. 
3.8.5 M. tuberculosis Exclusively Enriches 17 Pathways in the Presence of MTP 
Our canonical pathway analysis also showed that 17 of the 44 pathways that were enriched by the 
wild type strain were not enriched by the mutant strain (Figure 26). Amongst these, the Human 
Embryonic Stem Cell Pluripotency pathway was the highest enriched pathway whereas the Role of 
IL-17 A in Arthritis pathway was the lowest enriched. The majority of these pathways are associated 
with normal cellular biochemical processes, with Fatty Acid a-oxidation Pathway being the only host 
immune response-related pathway (Figure 27). 
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Figure 26: Pathways that were only enriched as a result of the wild type infection. MTP caused the 
enriched of these pathways in infected A549 epithelial cells. 
NAD+, aldehyde dehydrogenase and oxygen oxidoreductase molecules were the only expressed 
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Figure 27: Fatty acid a-oxidation Pathway. A low ranking canonical pathway associated with the 
host immune response that was exclusively enriched as a result of wild type infection. Molecules 
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associated with this pathway are displayed with red and green which indicate up- and down-regulated 
genes. The brighter the red or green colour, the more up- and down-regulated the molecule in A549 
epithelial cells, relative to unifected cells. Molecules shaded in white are part of the knowledge-based 
IP A software and were not expressed in our datasets. 
3.9. The Role of MTP in Host Immune Response 
Gene expression profiles ofDEGs associated with the host immune response were further investigated 
using a heat map (Figure 28). These included genes coding for various functions such as host-
pathogen interactions, immune and inflammatory response and immune cell activation. The level of 
up-regulation for all up-regulated genes was higher in genes induced by the wild type strain when 
compared to those induced by the mtp-mutant strain, while the level of down-regulation varied 
between the two conditions. The heat map also shows that the deletion of MTP results in down-
regulation of some of the genes that were up-regulated by the wild type strain. These findings further 
reveal the essential role that MTP plays in gene regulation of A549 epithelial cells. 
Both strains up-regulated genes associated with the complement system e.g. CJS, C3, C4BPA, C5, C6 
and C7. However, the level of up-regulation of these genes was highly induced by the wild type strain 
compared to the mutant. There was no significant up-regulation of C4BPB and C5ARJ by the mtp-
mutant strain while the wild type strain significantly up-regulated these genes. The majority of cell 
surface markers were down-regulated by both strains except for CD14, CD24, CD302, CD38, CD99, 
CD9 and CD96. Moreover, CD14, CD24, CD302, CD38 and CD99 were highly induced by the wild 
type strain compared to the mtp-mutant while the up-regulation of CD9 and CD99L2 by the mtp-
mutant strain was not significant. 
All genes associated with the ability of epithelial cells to present antigens (HLA genes) were down-
regulated except for HLA-DMA and HLA-DMB. The wild type strain highly up-regulated HLA-DMA 
when compared to the mtp-mutant strain. Both strains did not induce the up-regulation of cytokines in 
A549 alveolar epithelial cells except for IL-15 and IL-32. The wild type strain significantly up-
regulated these two cytokines while the mtp-mutant strain did not affect their expression. Both strains 
highly up-regulated the expression of chemokines in epithelial cells except for CCL20 and CXCL8 for 
the wild type strain and CCL5, CXCL6, CXCL8 and CCL20 for the mtp-mutant strain. These findings 
suggest that, in the absence of MTP, cytokine and chemokine response is negatively affected in A549 
epithelial cells. There was also differential expression in genes associated with tumor necrosis factor 







































































































































Figure 28: Host immune response-related DEGs induced as a result of infection of A549 epithelial 
cells with wild type and mtp-knockout mutant strains at 4 hr post-infection, relative to uninfected 
cells. Sequenced reads were mapped to the reference genome using TopHat. Cuffdiff of the RNA-
sequencing Tuxedo pipeline was used to identify DEGs between uninfected and infected epithelial 
cells. Red indicates up-regulated genes while green indicates down-regulated genes. 
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3.9.1. MTP Plays a Limited Role in Inducing Antigen Presentation by Epithelial Cells 
Our gene expression profiles indicate that the majority of genes involved in antigen presentation were 
down-regulated by both strains in A549 pulmonary epithelial cells, relative to uninfected cells. Up-
regulated genes (HLA-DMA and HLA-DMB) were highly up-regulated by the wild type strain 
compared to the mutant strain (Figure 29). 

























Figure 29: Antigen Presentation Signaling. The induction of DEGs involved in antigen presentation 
in A549 epithelial cells infected with the wild type and mtp-mutant strain for 4 hours. Sequenced 
reads were mapped to the reference genome using TopHat. Cuffdif.f of the RNA-sequencing Tuxedo 
pipeline was used to identify DEGs between uninfected and infected epithelial cells. Red indicates 
up-regulated genes while green indicates down-regulated genes. 
3.9.2. MTP Activates the Expression of Cell Surface Receptors in Epithelial Cells 
Cell surface receptors such as CD14, CD24, CD302, CD38, CD96, CD99 and CD99L2 were all up-
regulated by both strains. However, the level of up-regulation was higher in the wild type infection 
compared to the mutant infection (Figure 30). There was no significant expression of CD9 by the 
mutant strain while the wild type strain, up-regulated this surface marker. 
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Figure 30: Cell Surface Receptor Signaling. The induction of DEGs associated with cell surface 
receptor signalling in A549 epithelial cells infected with the wild type and mtp-mutant strain for 4 
hours. Sequenced reads were mapped to the reference genome using TopHat. Cuffdiff of the RNA-
sequencing Tuxedo pipeline was used to identify DEGs between uninfected and infected epithelial 
cells. Red indicates up-regulated genes while green indicates down-regulated genes. 
3.9.3. MTP Highly Induces Antibody Response via the Complement System in Epithelial Cells 
All DEGs involved in the complement system were up-regulated by both strains except for C2 and 
C4A (Figure 31 ). All up-regulated genes were highly induced by the wild type strain compared to the 
mutant strain. There was no significant differential expression for C4BPB and C5ARJ by the mtp-
mutant strain while the wild type strain highly up-regulated these genes. 
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Figure 31: Complement System Signalling. The induction of DEGs involved in the complement 
system in A549 epithelial cells infected with the wild type and mtp-mutant strain for 4 hours. 
Sequenced reads were mapped to the reference genome using TopHat. Cuffdiff of the RNA-
sequencing Tuxedo pipeline was used to identify DEGs between uninfected and infected epithelial 
cells. Red indicates up-regulated genes while green indicates down-regulated genes. 
3.9.4. MTP Induces Toll-like Receptor Signalling in Epithelial Cells 
Our gene expression profile analysis demonstrated the induction of TLR expression in infected 
epithelial cells. TLRs are host cell receptors that recognize microbial components as non-self, leading 
to the activation of immune responses to eliminate them (Takeda and Akira, 2005). These receptors 
play a huge role in the recognition of microbial components, which initiates signal transduction 
pathways and the activation of different genes in host cells (Takeda and Akira, 2005). TLRJ, TLR6, 
TLR7, TLR8 and TLRJO were up-regulated by both strains while TLR3, TLR4 and TLR9 were down-
regulated. The wild type strain highly expressed up-regulated TLRs when compared to the mtp-
mutant strain (Figure 32). There was no significant expression of TLR2 by the mutant strain while the 
wild type strain down-regulated the expression of this receptor. Both strains did not induce significant 
expression of TLR5 in A549 alveolar epithelial cells. 











Figure 32: Toll-like Receptor Signaling. The induction of DEGs associated with toll-like receptor 
signalling in A549 epithelial cells infected with the wild type and mtp-mutant strain for 4 hours. 
Sequenced reads were mapped to the reference genome using TopHat. Cuffdiff of the RNA-
sequencing Tuxedo pipeline was used to identify DEGs between uninfected and infected epithelial 
cells. Red indicates up-regulated genes while green indicates down-regulated genes. 
3.9.5. MTP Regulates Genes Associated with Immune Cell Activation 
DEGs involved in host immune cell activation were further investigated and displayed in Figure 33A 
and 33B below. These included genes coding for the activation of cytokine and chemokine receptors 
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and TNF receptor signalling. Both strains up-regulated the expression of genes coding for cytokines 
(JLJORA, ILl3RAJ, IL15RA, JLJRJ and IL6R) chemokines (CCR6, CCR7 and CXCR4) and tumor 
necrosis factor (TNFRSFJJB, TNFRSF13C, TNFRSFJ9, TNFRSFJA and TNFRSFJB) receptors while 
other receptors were down-regulated. The wild type strain highly induced the expression of all up-
regulated genes in epithelial cells compared to the mutant strain. 
A 
.............................. 






































Figure 33: Gene expression profiles of DEGs associated with Cytokine and Chemokine Receptor 
Signalling (A) and TNF Receptor Signalling (B) in A549 epithelial cells infected with the wild type 
and mtp-mutant strain for 4 hours. Sequenced reads were mapped to the reference genome using 
TopHat. Cuffdiff of the RNA-sequencing Tuxedo pipeline was used to identify DEGs between 
uninfected and infected epithelial cells. Red indicates up-regulated genes while green indicates down-
regulated genes. 
3.9.6. MTP Highly Induces the Expression of Chemokines in Epithelial Cells 
The role of MTP in inducing DEGs associated with the expression of chemokines in A549 epithelial 
cells was further investigated. Our gene expression analysis showed that the wild type strain up-
regulated the expression of all chemokines induced except for CCL20 while the mtp-mutant strain 
also up-regulated these chemokines except for CCL5 and CXCL8 chemokines. The level of expression 
in up-regulated chemokines was highly induced by the wild type strain compared to the mtp-mutant 
strain (Figure 34A). The induction of cytokines in A549 epithelial cells was largely down-regulated 
by both strains. The wild type strain up-regulated the expression of ILJ J, ILJ 5, and IL32 while the 
mutant strain up-regulated ILJ J only. There was no significant expression of !LI 8, !Li 8BP and TNF 
cytokines by the wild type strain while the same was true for ILJ 5 and IL32 by the mutant strain 
(Figure 34A). The pathway associated with differential regulation of cytokine production in 
macrophages and T-helper cells was highly enriched by the mtp-mutant strain in A549 epithelial cells 
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but the expression of DEGs involved in the pathway was similar for both strains (Figure 34B) while 
the IL6 upstream regulator was enriched by the wild type strain only (Figure 34C). 
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Figure 34: Cytokine and Chemokine Response Signalling. A: The induction of DEGs associated 
with cytokine and chemokine production in A549 epithelial cells infected with the wild type and mtp-
mutant strain for 4 hours. Sequenced reads were mapped to the reference genome using TopHat. 
Cuffdiff of the RNA-sequencing Tuxedo pipeline was used to identify DEGs between uninfected and 
infected epithelial cells. Red indicates up-regulated genes while green indicates down-regulated 
genes. B: Differential Regulation of Cytokine Production in Macrophages and T-helper Cells by IL-
17 A and IL-17F Pathway. This Canonical pathway was equally enriched by both strains. Expression 
profiles of DEGs involved in the pathway were also similar for both strains. Molecules associated 
with this pathway are displayed with red and green which indicate up- and down-regulated genes. The 
brighter the red or green colour, the more up- and down-regulated the gene in A549 epithelial cells, 
relative to unifected cells. Molecules shaded in white are part of the knowledge-based IPA software 
and were not expressed in our datasets. The legend below the image shows different molecules 
displayed on the pathway. C: A mechanistic network involving IL6 upstream regulator that was only 
enriched by the wild type strain in A549 epithelial cells. The legend on the right hand side of the 
image shows different molecules represented and different inter-relationships they have with IL6 and 
with one another. Molecules shaded in white are part of the knowledge-based IP A software and were 
not expressed in our datasets. 
3.9.7. MTP Expresses STAT Response Signalling in A549 Epithelial Cells 
Our gene expression profiles further revealed that the wild type strain highly induced the expression 
of genes coding for STAT 1, STAT3 and STAT6 compared to the mtp-mutant strain while STAT5A and 
STAT5B were down-regulated by both strains (Figure 35A). There was no significant expression of 
STAT2 and STAT4 genes by the wild type strain and STAT2 and STAT6 by the mtp-mutant strain. A 
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Figure 35: S TAT Response Signalling. A: The induction of DEGs associated STAT response 
signalling in A549 epithelial cells infected with the wild type and mtp-mutant strain for 4 hours. 
Sequenced reads were mapped to the reference genome using TopHat. Cuffdiff of the RNA-
sequencing Tuxedo pipeline was used to identify DEGs between uninfected and infected epithelial 
cells. Red indicates up-regulated genes while green indicates down-regulated genes. B: A 
mechanistic network involving STATl upstream regulator that was only enriched by the mtp-mutant 
strain in A549 epithelial cells. The legend on the right hand side shows different molecules 
represented and different inter-relationships they have with STATl and with one another. 
3.9.8. MTP Induces TNF Response Signalling in Epithelial Cells 
The impact MTP has on inducing cell death in A549 epithelial cells in response to wild type and mtp-
mutant infection was also investigated where the majority of the genes associated with TNF Response 
Signalling were found to be up-regulated by both strains. However, the level of up-regulation for 
these genes differed between the two infection conditions. All the up-regulated genes were highly 
enriched by the wild type strain when compared to the mutant strain (Figure 36). TNFSF 11 was up-
regulated by the wild type strain while it was down-regulated by the mutant strain. There was no 
significant expression of TNFSFl 3 in A549 alveolar epithelial cells by both strains . 
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Figure 36: TNF Response Signaling. The induction of DEGs associated TNF response signalling in 
A549 epithelial cells infected with the wild type and mtp-mutant strain for 4 hours. Sequenced reads 
were mapped to the reference genome using TopHat. Cujfdiff of the RNA-sequencing Tuxedo 
pipeline was used to identify DEGs between uninfected and infected epithelial cells. Red indicates 
up-regulated genes while green indicates down-regulated genes. 
3.10. Network Analysis 
To further understand the biology encoded by SDEGs induced in A549 epithelial cells in response to 
wild type and mtp-mutant infection, knowledge-based software, IP A, was used to investigate 
networks enriched by these genes in infected cells, relative to uninfected cells. SDEGs elicited in 
A549 epithelial cells infected with the wild type and mtp-mutant strain enriched an equal number (25) 
of networks (Table 12). Further network analysis showed that both strains enriched 5 networks that 
were associated with similar top diseases and biological functions. SDEGs that were uniquely induced 
as a result of wild type and mtp-mutant infection in A549 epithelial cells enriched 21 and 11 
networks, respectively. Uniquely induced SDEGs did not enrich similar networks in A549 epithelial 
cells, relative to uninfected cells (Table 12). 
Table 12: Biological networks enriched by SDEGs in A549 epithelial cells in response to wild type 
and mtp-mutant infection, relative to uninfected cells. 
Uninfected SHARED Uninfected vs UNIQUE UNIQUE 
vs WT MUTANT WT MUTANT 
Networks 25 5 25 21 11 
3.10.1. Network Enrichment by the mtp-mutant strain 
The mtp-mutant strain enriched a total of 25 networks in A549 pulmonary epithelial cells, relative to 
uninfected cells. The top scoring network (Network 1, Table 13) enriched by the mtp-mutant strain 
had a score of 55 with 34 interacting molecules involved in cellular assembly and organisation, DNA 
replication, recombination, and repair and post-translational modification (Figure 37). Network 1 and 
Network 13 were associated with similar top diseases and biological functions. However, the latter 
was lowly ranked and had less interacting molecules when compared to the former (Table 13). This 
trend was also observed in Network 5 and Network 10. 
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Table 13: Top 15 networks enriched by SDEGs induced by the mtp -mutant strain in A549 pulmonary 
epithelial cells, relative to uninfected cells. 































Cellular assembly and organisation, DNA replication, 
recombination, and repair, post-translational modification. 
Connective tissue disorders, developmental disorder, hereditary 
disorder. 
Cell cycle, cellular assembly and organisation, DNA replication, 
recombination, and repair. 
Cell cycle, cellular development, cell death and survival. 
Cell cycle, cancer, organismal injury and abnormalities. 
Neurological disease, connective tissue development and function, 
embryonic development. 
Gene expression, cellular development, cell cyde. 
· ··-· ' - . . --.._ _ · . . ·.., - : ;. 
Cardiovascular disease, cell death and survival, connective tissue 
disorder. 
Connective tissue disorders, developmental disorder, 
gastrointestinal disease. 
Cancer, cell cycle, organismal injury and abnormalities. 
Cancer, endocrine system disorders, organismal injury and 
abnormalities. 
- .. > : 
Cellular assembly and organization, cell cycle, post-translational 
modification. 
Ceifolar assembiy and orga:nisatiort: DNA replication, 
recombination, and repair, post-translational modification . 
. ,..._ '. , · :-_ __ .._ ·- ~~ .... - '-" - ·.. . .·. -... ·'··- - - - -. 
Immunological disease, cellular function and maintenance, cellular 
development. 
Cell-to-cell signalling and interaction, cellular growth and 
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Figure 37: Top scoring (55) network of most up- and down-regulated SDEGs that were induced by 
the mtp-mutant strain in A549 epithelial cells, in relation to uninfected cells. The network was 
associated with top biological functions such as cellular assembly and organisation, DNA replication, 
recombination, and repair, post-translational modification. The legend represents different types of 
molecules present on the network. Red represents up-regulated while green represents down-regulated 
SDEGs. The brighter the red or green colour, the more up- or down-regulated the gene. DEPDCJ, 
FOXMJ, KIF2C, KIF4A and HISTJH3B were the most up-regulated molecules, whereas 
BHLHE4lwas the most down-regulated. 
3.10.2. Network Enrichment by the wild type strain 
The wild type strain enriched a similar number of networks (25) in A549 epithelial cells when 
compared to the mutant strain. The top scoring network (Network 1, Table 14) had a ranking score of 
42 and 30 interacting molecules associated with cell cycle, cellular development, cell death and 
survival (Figure 38). Network 3 and Network 4 were associated with similar top diseases and 
biological functions. However, the latter was lowly ranked and had one less interacting molecules 
when compared to the former (Table 14). 
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Table 14: Top 15 networks enriched by SDEGs induced by the wild type strain in A549 pulmonary 
epithelial cells, relative to uninfected cells. 






























Cell cycle, cellular development, cell death and survival. 
Connective tissue disorders, developmental disorder, 
gastrointestinal disease. 
Cell cycle, cellular assembly and organisation, DNA replication, 
recombination, and repair. 
Cell cycle, cellular assembly and organisation, DNA replication, 
recombination, and repair. 
Cellular development, cellular growth and proliferation, 
reproductive system development and function. 
Energy production, small molecule biochemistry, endocrine system 
development and function. 
Cell cycle, cellular movement, cellular assembly and organization. 
. •-. .,,. . - _. _,. _., . ._ .. ·· ~ .... ~ - . 
Hereditary disorder, metabolic disease, organismal injury and 
abnormalities. 
Connective tissue d.lsorciers, developmental disorder~ hereditary 
disorder. 
Cell cycle, DNA replication, recombination, and repair, 
cardiovascular disease. 
Cell-to-cell signalling and interaction, celluiar growth and 
proliferation, connective tissue development and function. 
Immunological disease, inflammatory disease, inflammatory 
response. 
Carbohydrate metabolism, lipid metabolism, molecular transport. 
.... - . ' - . . ~·. ·· .. .. ···: . -- ~--
Cell-to-cell signalling and interaction, haematological system 
development and function, cancer. 
Cellular assembly and organisation, DNA replication, 
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Figure 38: Top scoring (42) network of most up- and down-regulated SDEGs that were induced by 
the wild type strain in A549 epithelial cells, in relation to uninfected cells. The network was 
associated with cell cycle, cellular development, cell death and survival. The legend represents 
different types of molecules present on the network. Red represents up-regulated while green 
represents down-regulated SDEGs. The brighter the red or green colour, the more up- or down-
regulated the gene. There was an overexpression of UBE2C while DPF3 was highly down-regulated. 
3.10.3. Network Enrichment by SDEGs Uniquely Induced by the wild type and mtp-mutant strain 
Further network analysis showed that SDEGs uniquely induced by the wild type strain in A549 
epithelial cells enriched 21 networks (Table 16) while those that were uniquely induced by the mtp-
mutant strain enriched 11 networks (Table 15), suggesting the importance of MTP in gene regulation 
of epithelial cells. The top scoring network (Network 1, Table 15) enriched by SDEGs uniquely 
induced by the mtp-mutant strain in A549 epithelial cells had a ranking score of 39 with 19 interacting 
molecules associated with cellular function and maintenance, connective tissue development and 
function and tissue morphology (Figure 39) while the top scoring network (Network 1, Table 16) 
enriched by SDEGs uniquely induced by the wild type strain had a ranking score of 45 with 25 
interacting molecules involved in cell signalling, molecular transport and nucleic acid metabolism 
(Figure 40). SDEGs that were uniquely induced by the mtp-mutant strain in A549 epithelial cells 
enriched low ranking networks with fewer interacting molecules when compared to those that were 
enriched by SDEGs that were exclusively elicited by the wild type strain. This analysis reveals that 
the absence of MTP affects the regulation of gene expression in epithelial cells in vitro. 
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Table 15: Networks enriched by SDEGs uniquely induced by the mtp-mutant strain in A549 
pulmonary epithelial cells, relative to uninfected cells. 
Rank Score Top Diseases and Functions Number of 
Interacting 
Molecules 
1 39 Cellular function and maintenance, connective tissue development 19 
and function. tissue morphology. 
2 36 Post-translational modification, protein folding, cellular 18 
compromise. 
3 29 Cellular development, embryonic development, haematological 15 
system development and function. 
4 24 Cell death and survival, neurological disease, cellular development. 13 
5 24 Embryonic development, lymphoid tissue structure and 13 
development, organ development. 
6 21 Cell death and survival, cellular compromise, gene expression. 12 
7 2 Amino acid metabolism, cancer, carbohydrate metabolism. 1 
--·~ .. ' ~ 
8 2 Endocrine system disorders, hereditary disorder, organismal injury 1 
and abnormalities. 
9 2 Cancer, connective tissue disorders, dermatological diseases and 1 
conditions. 
10 2 Inflammatory response. 1 






























Figure 39: Top scoring (39) network of most up- and down-regulated SDEGs that were uniquely 
induced by the mtp-mutant strain in A549 epithelial cells, in relation to uninfected cells. The network 
was associated with cellular function and maintenance, connective tissue development and function, 
tissue morphology as a result of elevated up- and down-regulation of molecules such as KLF2 and 
JLJ RLJ. The legend represents different types of molecules present on the network. Red represents 
up-regulated while green represents down-regulated SDEGs. The brighter the red or green colour, the 
more up- or down-regulated the gene. 
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Table 16: Top 15 networks enriched by SDEGs uniquely induced by the wild type strain in A549 
pulmonary epithelial cells, relative to uninfected cells. 































Cell signalling, molecular transport, nucleic acid metabolism. 
Cell-to-cell signalling and interaction, lymphoid tissue structure 
and development, tissue morphology. 
Molecular transport, energy production, embryonic development. 
Lipid metabolism, small molecule biochemistry, infectious 
diseases. 
Connective tissue disorders, developmental disorder, hereditary 
disorder. 
Developmental disorder, organismal injury and abnormalities, 
reproductive system disease. 
Reproductive system development and fwiction, ceillilar function 
and maintenance, organ development. 
-·· ·--
Cellular development, haematological system development and 
function, hematopoiesis. 
Nervous systerri development and function, organ-morphology, 
organismal development. 
:.. -. . ·. '~· "·' ·~'. . " .... _ 
Cancer, cell cycle, cell-to-cell signalling and interaction. 
celi death and survival, haematological system development and 
function, lymphoid tissue structure and development. 
:· o" - - ·•·. ~ •·--' •' ·' 
Cell death and survival, cellular development, cellular function and 
maintenance. 
Neurological disease, gene express1on, RNA damage and repair. 
- - " -- ..... _ ~ - .. , --- --
Cell cycle, carbohydrate metabolism, lipid metabolism. 
Celliliar growth amf proliferation, haematological system 




















Figure 40: Top scoring (45) network of most up- and down-regulated SDEGs that were uniquely 
induced by the wild type strain in A549 epithelial cells, in relation to uninfected cells. The network 
was associated with cell signalling, molecular transport, nucleic acid metabolism. The legend 
represents different types of molecules present on the network. Red represents up-regulated while 
green represents down-regulated SDEGs. The brighter the red or green colour, the more up- or down-
regulated the gene. VIP was the most down-regulated molecule while NR5A, AQP3 and ANXA4 were 
most up-regulated. 
3.10.4. Common Networks Enriched by SDEGs Induced by the wild type and mtp-mutant strain 
Our network analysis showed that SDEGs elicited by both wild type and mtp-mutant strains in A549 
epithelial cells enriched 5 networks with similar top diseases and biological functions. However, there 
was a variation in the network ranking and score, as well as the number of interacting molecules 
involved in each shared network (Table 17). Overall, the wild type strain enriched top scoring 
common networks in A549 epithelial cells compared to those enriched by the mtp-mutant strain. 
These findings suggest that the presence of MTP in M tuberculosis leads to the enrichment of top 
scoring networks with a high number of interacting molecules that are up- and down-regulated by 
A549 epithelial cells in response to infection. 
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Table 17: Common networks enriched by SDEGs induced by the wild type strain and mtp-mutant 
strain in A549 pulmonary epithelial cells, relative to uninfected cells. 
Strain Rank Score Top Diseases and Function Interacting 
Molecules 
wild type 15 24 Cellular assembly and organisation, DNA 21 
mtp-mutant I 55 replication, recombination, and repair, 34 
13 28 post-translational modification. 22 
wild type 3 40 Cell cycle, cellular assembly and 29 
4 37 organisation, DNA replication, 28 
mtp-mutant 3 35 recombination, and repair. 26 
wild type 1 42 Cell cycle, cellular development. cell death 30 
mtp-mutant 4 35 and survival. 26 
wild type 2 40 Connective tissue disorders, developmental 29 
mtp-mutant 9 31 disorder, gastrointestinal disease. 24 
wild type 23 19 Organismal injury and abnormalities, 18 
mtp-mutant 18 20 developmental disorder, haematological 18 
disease. 
3.11. Upstream Regulator Analysis 
To further understand the effects and role of MTP in gene regulation of A549 epithelial cells, 
knowledge-based IP A software was used to investigate the enrichment of upstream regulators in A549 
epithelial cells infected with the wild type and mtp-mutant strain. IP A upstream regulator analysis 
enables the identification of a cascade of upstream transcriptional regulators that can explain observed 
gene expression changes in our datasets and elucidate biological activities taking place in A549 
epithelial cells infected with the wild type and mtp-mutant strain. The up- or down-regulation of these 
regulators may not always correlate with the information contained in our datasets as IP A gets 
updated on a regular basis. The wild type and mtp-mutant strain enriched 18 and 32 upstream 
regulators in A549 epithelial cells, respectively, relative to uninfected cells. A total of 10 (Appendix 
8) and 24 (Appendix 9) upstream regulators were exclusively enriched by wild type and mtp-mutant 
strain, respectively (Figure 41) while 8 were enriched by both strains (Appendix 7). The enrichment 
of a high number of upstream regulators by the mtp-mutant strain in A549 epithelial cells, compared 
to the wild type, suggests that the loss of MTP in M. tuberculosis could result in an elevated response 










Figure 41: Upstream regulators that were induced by the wild type and mp-mutant strain in A549 
pulmonary epithelial cells. A 2-way Venn diagram shows that 18 and 32 upstream regulators were 
enriched by the wild type and mtp-mutant strain, respectively. The wild type and mtp-mutant strain 
exclusively enriched 10 and 24 upstream regulators in epithelial cells, respectively, while 10 upstream 
regulators were commonly enriched by both strains. 
CEBPD, E2FI and FOXMI upstream regulators were up-regulated by both strains. However, CEBPD 
was highly enriched by the wild type strain compared to the mutant strain while STAT3 was up-
regulated by the wild type strain and not significantly expressed by the mutant strain (Figure 42). 
CCNDI, NUPRI and SMARCA4 were down-regulated by both strains while there was no significant 
expression for TP53. 









Figure 42: Gene expression profiles showing upstream regulators that were commonly induced by 
both strains in A549 pulmonary epithelial cells, relative to uninfected cells. Red represents up-
regulated while green represents down-regulated. The more intense red or green colour, the higher up-
regulation and down-regulation. 
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3.11.1 Upstream Regulators Exclusively Enriched by the mutant strain 
The mtp-mutant strain exclusively enriched 24 upstream regulators in A549 pulmonary epithelial 
cells, with 13 and 11 being up and down-regulated, respectively (Table 18). In our dataset, MYBL2 
was the most up-regulated upstream regulator with a fold change of 7.75 while other up-regulated 
regulators had fold changes ranging from 0 to 1.5. A similar trend was also observed in down-
regulated upstream regulators where MYC was the only highly down-regulated regulator with a fold 
change of -2.30 while other down-regulated regulators had fold changes ranging from -0.02 to -0.83. 
Table 18: Upstream regulators exclusively induced by the mtp-mutant strain in A549 pulmonary 





























3.11.2 Upstream Regulators Exclusively Enriched by the wild type strain 
The wild type strain exclusively enriched 10 upstream regulators in A549 pulmonary epithelial cells 
(Table 19). A total of 6 and 4 upstream regulators were up and down-regulated, respectively. HGF 
was the highest up-regulated upstream regulator whereas ESRJ was the lowest up-regulated. CSF2 
and IRFJ were the highest and lowest down-regulated upstream regulators respectively. 
Table 19: Upstream regulators exclusively induced by the wild type strain in A549 pulmonary 















CHAPTER 4: DISCUSSION 
Since the seminal paper describing the presence of pili in M tuberculosis (Alteri et al., 2007), 
research in this field, has been steadily gaining momentum to further characterize this pathogen' s curli 
pili (MTP) to interrogate its potential as a biomarker for rapid diagnostics and therapeutic 
interventions (Govender et al., 2014; Naidoo et al., 2014; Ramsugit and Pillay, 2015). However, this 
research area is still in its infancy, and its complete role in host pathogen interaction remains 
unknown. In this study, for the first time RNA-Seq was used to investigate the global transcriptomics 
of infected pulmonary epithelial cells to elucidate the in vitro role of MTP in gene regulation and 
pathway and network analysis using a mtp gene knockout mutant of M tuberculosis. 
The epithelial cell model was chosen due to the increasing body of evidence demonstrating that M 
tuberculosis is able to invade and survive inside these cells (McDonough and Kress, 1995; Bermudez 
and Goldman, 1996; Lin et al., 1998; Dobos et al., 2000; Castro-Garza et al., 2002; Mvubu et al., 
2016; Ramsugit et al., 2016). Epithelial cells may be the first point of contact with the pathogen due 
to their over-representation in the alveolar space compared to macrophages (Li et al., 2012). M 
tuberculosis uses cell surface-bound molecules called adhesins, in order to adhere to, and invade 
epithelial cells (Ryndak et al., 2015), and is known to produce multiple adhesins in order to enhance 
its entry into host cells via extracellular matrix proteins (Ryndak et al., 2015). Recent studies have 
suggested that MTP may be a major adhesin and invasin of macrophages (Ramsugit and Pillay, 2014) 
and epithelial cells (Ramsugit et al., 2016) by binding to the laminin protein of the extracellular 
matrix in vitro (Alteri et al., 2007) but does not largely influence the overall cytokine response in 
epithelial cells (Ramsugit et al., 2016). 
In this study, the number of invaded bacteria observed in A549 cells infected with the wild type strain 
did not differ significantly when compared to the mutant strain after 4 hours of infection. However, 
our results showed that, as a result of mtp deletion, the number of significantly differentially 
expressed genes and canonical pathways induced in A549 epithelial cells was reduced, suggesting that 
MTP regulates gene expression in epithelial cells in vitro. These findings suggest that the differences 
in the gene expression levels and canonical pathways are not attributed to significant differences in 
the bacterial count but are due to deletion of the mtp gene. 
Curli pili have been shown to play a role in invasion of human cervical epithelial cells (Gophna et al. , 
2001) and Hep-2 cells by E. coli (Uhlich et al., 2002) as well as in adhesion of cultured mouse small 
intestine epithelial cells by Salmonella typhimurium (Sukupolvi et al. , 1997). In addition to epithelial 
cells, loss ofMTP in M. tuberculosis was also shown to decrease adhesion to, and invasion of THP-1 
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monocyte derived macrophages, whilst complementation of MTP resulted in an increased expression 
of the mtp gene compared to the wild type (Ramsugit and Pillay 2014). 
4.1. MTP Induces Differential Gene Expression in A549 Pulmonary Epithelial Cells 
The role of the MTP adhesin of M tuberculosis in gene regulation of human alveolar epithelial cells 
was elucidated by investigating the number of significantly differentially expressed host genes due to 
infection by the wild type and mutant strain. The wild type strain induced the highest total number 
(917) of genes when compared to the mutant (725) while 610 genes were expressed by both strains. 
This reduction by 12%, in the number of genes expressed by the mutant strain shows that MTP plays 
an important role in gene regulation of alveolar epithelial cells. 
The expression of 610 genes by M. tuberculosis infection remained unaffected by MTP as these were 
induced by both strains, 345 (57%) of which were up-regulated while 265 (43%) were down-regulated 
Gene ontology analysis showed that up-regulated genes were associated with essential biological 
functions such as cell cycle and cell division, regulation of cell-to-cell adhesion, DNA replication, 
signal transduction, complement system as well as antigen presentation via MHC Class Il. Down-
regulated genes were associated with cell communication, enzyme binding, regulation of cellular 
metabolic processes, lymphocyte activation and cell surface receptor signalling pathway. 
Chen et al. (2015) also demonstrated a higher number of up-regulated than down-regulated genes 
when RNA-sequencing was used to elucidate the response of lung epithelial cells infected with A. 
fumigatus. Using a cut off fold change of 1.5 or greater, they found 302 (66%) up-regulated and 157 
(34%) down-regulated genes. Their gene ontology enrichment analysis showed that up-regulated 
genes were associated with immune response, chemotaxis, positive regulation of macromolecule 
processes, cell activation, response to bacterium, regulation of transcription and response to stimulus. 
Down-regulated genes were mainly enriched for skeletal system development, hemopoiesis, ion 
transport and immune response. Collectively, these two sets of findings suggest a general response 
induced in pulmonary epithelial cells as a result of bacterial infection. 
Differences in the number of differentially expressed genes as well as biological functions they are 
associated with are most likely attributed to the different infecting pathogens. Ryndak et al. (2015) 
used microarray technology to investigate the transcriptional profile of M. tuberculosis H37Rv 
replicating in A549 alveolar epithelial cells compared to H37Rv actively growing in broth. After 72 
hours of replication inside A549 cells, 261 M tuberculosis genes were differentially expressed, with 
186 and 75 genes up- and down-regulated respectively. Up-regulated genes were associated with 
tryptophan synthesis and increased virulence whereas down-regulated genes were associated with 
stress and heat shock response and DosR regulon (Ryndak et al., 2015). 
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In this study, loss of MTP resulted in a lower number, 115 (27%) of genes induced only by the mutant 
strain compared to 307 (73%) by the wild type strain. However, both strains induced a higher number 
of up-regulated genes compared to down-regulated genes. The wild type strain uniquely up-regulated 
genes associated with cell communication (ERBB3, GSG2, HISTJH4B, HJST1H4C, IL6ST, IFITM3, 
IGF2), signal transduction (ABCC9, ADCY5, ADM, ANXA4, BCAM, CALY, IL6ST), response to lipids 
(ADCY5, ADM, APOH, AQP3) and chemical stimulus (ACY3, ADCY5, ADH6, CXCL3, EDNl, 
ERBB3, IFITM3) (Table 9). These included host immune response-related IL6ST cytokine and 
CXCL3 chemokine. IL6ST is a major signal inducer that plays an essential role in increasing the 
binding affinity of the IL6 receptor (Waetzig et al., 2010). It is also involved in the activation of the 
STAT3 transcriptional factor (Schutt et al., 2013) and mediates signals which regulate pain control, 
hematopoiesis and immune response (Waetzig et al., 2010). 
The CXCL3 chemokine, together with CCL2, CCL20, CXCLJ and CXCL2, have been reported to be 
expressed by infected epithelial cells in response to Girdia lamblia infection (Roxstrom-Lindguist et 
al., 2005). The up-regulation of these chemokines is essential for the induction of both the innate and 
adaptive immunity (Roxstrom-Lindguist et al., 2005). CXCLl, CXCL2, CXCL3 and CXCL5 are 
induced in lung tissue upon M tuberculosis infection (Nouailles et al., 2014). The up-regulation of 
CXCL3 and IL6STby epithelial cells in the presence of MTP only, implies the essential role it plays in 
inducing pro inflammatory response in host cells. 
M tuberculosis has been known to induce immune response in macrophages by eliciting cytokine and 
chemokine production which leads to the recruitment of neutrophils, dendritic and natural killer cells 
towards the site of infection (Welin, 2011; Peters and Ernst, 2003; Fogel, 2015). Previous studies 
conducted using RT-PCR have implicated human alveolar epithelial cells in the production of IL-8 
and MCP-1 (Lin et al., 1998), CXCL-10, TNF-a and CCL-5 (Lam et al., 2010) and IL-1/3, IL-6, TNF-a 
and MCP-1 (Savard et al., 2002) contributing to the activation of immune cells and pro inflammatory 
response (DiMango et al., 1995; Jung et al., 1995; Lin et al., 1998). Genes associated with cell 
differentiation and regulation of biosynthetic processes were down-regulated by the wild type strain. 
Interestingly, genes involved in cell communication and signal transduction were both up and down-
regulated by the wild type strain. This could mean that these biological functions are coded for by 
different sets of genes which are significantly down and up-regulated in pulmonary epithelial cells in 
vitro. 
The mutant strain exclusively up-regulated genes associated with biological functions such as protein 
refolding, cellular response to stress and positive regulation of tumor necrosis factor associated-
pathways. All these biological functions were driven by heat shock proteins. Van Eden et al. (2005) 
reported that immune response to heat shock proteins develops in almost all inflammatory diseases, 
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resulting in the prevention of cell damage due to inflammation. These proteins are up-regulated by 
host cells in order to arrest inflammatory damage and their peptides have been implicated in 
promoting the production of anti-inflammatory cytokines, indicating a potential ability to regulate the 
immune system (Van Eden et al., 2005). Inflammatory response to infections leads to the up-
regulation of tumor necrosis factor pathways which often results in disruption of the epithelial cell 
barrier (Mashukova et al., 2010). Therefore, the expression of genes coding for cytokines and tumor 
necrosis factor response in mutant infected-epithelial cells could be attributed to the up-regulation of 
heat shock proteins by these cells. By inference, MTP prevents disruption to epithelial cells, most 
likely in order to protect its replication niche. Genes associated with cellular processes and ion 
binding were down-regulated by the mutant strain. This could suggest that MTP affects essential 
cellular processes once it invades epithelial cells. 
4.2. MTP Enriches a High Number of Canonical Pathways in Epithelial Cells 
Changes in canonical pathways were investigated with IP A using datasets of significantly 
differentially expressed genes. The wild type strain enriched a higher number of pathways i.e. 44 
(59%) compared to 30 (41 %) by the mutant strain. These results suggest that MTP plays an important 
role in gene regulation of alveolar epithelial cells which is evident from its involvement in the 
enrichment of a high number of canonical pathways and the lower number of pathways enriched in its 
absence. A total of 27 pathways was unaffected by MTP as these were enriched by both strains. The 
majority of these pathways, 23 (85%), were highly enriched by the mutant strain compared to the wild 
type strain. A possible explanation for this may be that the mutant strain compensates for the loss of 
the mtp gene by up-regulating genes coding for other adhesins which, in tum, could lead to elevated 
levels of pathway enrichment by the mutant strain. 
Mvubu et al. (2016) reported that hyper-virulent strains induced lower protective response as 
displayed by low enrichment of immune related canonical pathways when compared to less virulent 
strains. Similarly, this could explain the low pathway enrichment by the wild type strain used in our 
study compared to the mutant strain which may present with reduced virulence upon loss of the mtp 
gene. Clinical M. tuberculosis strains representing major strain families in South Africa have also 
been shown to induce specific molecular pathways in A549 epithelial cells after 48 hours of infection 
(Mvubu et al., 2016). In this study, after 4 hr, pathways such as Role ofIL-17A in Athritis and Fatty 
Acid Oxidation pathways were exclusively induced by the wild type strain of the F15/LAM4/K.ZN 
family compared to Dendritic Cell Maturation, Role of Pattern Recognition Receptors in Recognition 
of Bacteria and Viruses and Antigen Presentation pathways that were enriched by the same strain at 
48 hr (Mvubu et al., 2016). 
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The Acute Phase Response Signalling pathway was enriched by both wild type and mutant strains in 
our study, with-log (p value) of 2.908 and 3.095, respectively. The Hepatic Fibrosis/Hepatic Stellate 
Cell Activation pathway was only enriched by the wild type strain. Mvubu et al. (2016) reported the 
enrichment of the Hepatic Fibrosis/Hepatic Stellate Cell Activation pathway by Fl 5/LAM4/KZN, 
H37Rv, Unique, F28, Fl 1 and Beijing strains of M tuberculosis 48 hr post-infection while the Acute 
Phase Response Signalling pathway was enriched by Fl5/LAM4/KZN, Beijing, Unique and F28 
strains. While the role of the MTP adhesin in adhesion to and invasion of macrophages (Ramsugit et 
al.,2015) and epithelial cells (Ramsugit et al., 2016) has been previously demonstrated, to our 
knowledge, no published data is available that elucidates the role of this and other bacterial adhesins 
in host gene regulation and canonical pathway enrichment. 
MTP did not affect certain host responses as both strains enriched pathways associated with host 
immune response e.g. acute phase response signalling pathway (Figure 20), complement system 
(Figure 21) and a pathway for differential regulation of cytokine production in macrophages and T 
helper cells (Figure 34). All these pathways were highly enriched by the mutant strain compared to 
the wild type strain. In the acute phase response signalling pathway, both strains up-regulated 
PL3KIP85 complex, SERPINAJ, CP, SERPINA3, FGG, FGB, FGA, LBP, CFB, AMBP, CFOS and 
C4BP genes while IL-6 was the only down-regulated gene. The wild type strain exclusively up-
regulated GP 130 and APOH genes whereas C3, which is very essential for the acute phase response, 
was exclusively up-regulated by the mtp-mutant strain. The up-regulation C3 by the mtp-mutant strain 
only, may be responsible for the high enrichment of the acute phase response signalling pathway in 
this strain compared to the wild type. The acute phase signaling pathway is involved in immune 
response to infection, tissue injury and inflammation (Moshage, 1997). This pathway has been 
implicated in the induction of acute phase proteins which restore homeostasis and is mediated by 
cytokines (Moshage, 1997). 
Both strains up-regulated C4BP, BF, IF, HFJ, DF, BFA and BFB genes of the complement system 
pathway, implying that the absence ofMTP did not affect this pathway. The mutant strain exclusively 
up-regulated C3, C3A and C3B genes of the alternate pathway wing in the complement system 
pathway. The high enrichment of the complement system pathway by the mutant strain, compared to 
the wild type strain, could be attributed to the exclusive up-regulation of C3, C3A and C3B. The 
complement system uses a cascade of soluble proteins and antibody complexes that function by 
opsonising invading bacteria, clumping and neutralization of bacterial antigens, as well as lysis of 
bacterial cells (W elin, 2011 ). The enrichment of the Differential Regulation of Cytokine Production in 
Macrophages and T-helper Cells by IL-17 A and IL-17F Pathway by both wild type and mutant strains 
correlated with the findings of Ramsugit et al. (2016) that demonstrated the ability of M tuberculosis 
V9124 wild type and mtp-knockout mutant strain to elicit cytokine production in A549 alveolar 
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epithelial cells. The interaction of pili with host cell receptors was reported to play an important role 
in the induction of inflammation through the production of inflammatory factors such as cytokines 
and chemokines (Sauer et al., 2000). Our results suggest that epithelial cells also play a role in the 
regulation of cytokine production in other immune cells such as macrophages and T helper cells as 
shown by the enrichment of the Differential Regulation of Cytokine Production in Macrophages and 
T-helper Cells by IL-17 A and IL-l 7F Pathway. In this pathway, the expression of IL-12 and CCL2 
was down- and up-regulated respectively in both macrophages and T-helper cells whereas IL-6 was 
down-regulated in the former and not expressed in the latter. 
In the absence of the mtp gene, only 3 unique canonical pathways were enriched compared to 17 
when the gene was present. These findings suggest that the presence of MTP leads to the regulation of 
17 cellular and immune response-related processes that are not regulated when the adhesin is absent. 
The mutant strain uniquely enriched the p53 Signaling Pathway, Salvage Pathways of Pyrimidine 
Deoxyribonucleotides and Glioma Invasiveness Signalling Pathway. The p53 Signalling Pathway is 
involved in response to stress that can disrupt DNA replication and cell division (Harris and Levine, 
2005) whereas the Glioma Invasiness Pathway is associated with the invasion of normal brain cells by 
tumor cells (Rao, 2003). 
Among 17 pathways that were uniquely enriched by the wild type strain were the Fatty Acid 
Oxidation Pathway, Role of IL-17A in Arthritis and the Pyruvate Fermentation to Lactate Pathway. 
According to Simon and Hertig (2015), epithelial cells alter the oxidation of fatty acids under 
biological stress. Therefore, it is tempting to speculate that MTP may be associated with the presence 
of the abundance of fatty acids in the cell membrane of M tuberculosis. The enrichment of the 
Pyruvate Fermentation to Lactate Pathway by the wild type strain only could suggest that MTP may 
be responsible for the induction of the Warburg effect in epithelial cells which allows mycobacterial 
proliferation. Microorganisms proliferate using fermentation, an equivalent of aerobic glycolysis, 
which allows the metabolism of glucose to lactate and provides sufficient energy, in a form of ATP, 
for cell proliferation (Vander Heiden et al., 2009). Kirkham et al. (2014) reported the involved of IL-
17 A in autoimmune diseases such as psoriasis, psoriatic arthritis and rheumatoid arthritis. The 
enrichment of the Role of IL-17 A in Arthritis pathway by the wild type strain could imply the 
involvement of MTP in the induction of autoimmune diseases in the host. 
4.3. MTP Induces a Strong Immune Response in A549 Epithelial Cells 
Differentially expressed genes associated with the host immune response as a result of infection of 
A549 pulmonary epithelial cells were induced by both strains. These included genes coding for 
various functions, such as host-pathogen interactions, immune and inflammatory response and 
immune cell activation. The level of up-regulation for all up-regulated genes was higher in the wild 
89 
type infection compared to the mutant infection. The level of down-regulation varied between the 
two conditions. Our findings also show that the deletion of MTP resulted in down-regulation of some 
of the genes that were up-regulated in the wild type infection. These findings suggest that the presence 
of the MTP adhesin in the wild type strain plays an important role in the launch of a strong immune 
response against this strain, while the knocking out of the mtp gene negatively affects the ability of 
epithelial cells to respond to M. tuberculosis infection. 
4.3.1. MTP Activates the Expression of Cell Surface Receptors in Epithelial Cells 
Cell surface receptors such as CDJ4, CD24, CD38, CD96 and CD99 were found to be more up-
regulated by the wild type strain when compared to the mutant strain. These surface-bound molecules 
function as essential cell surface co-receptors (alongside TLRs) for the detection of bacterial 
lipopolysaccharides (Jersmann, 2005), lipoteichoic acid, glycolproteins (Jaggupilli and Elkord, 2012), 
proteins and carbohydrates. TLRs are intracellular and surface-bound receptors that are involved in 
the recognition of lipoproteins, lipids and extracts of M. tuberculosis and other pathogens (Welin, 
2011). In our study, genes coding for TLRI, TLR6, TLR7, TLR8 and TLRJO were highly up-regulated 
by the wild type strain than the mutant strain. Takeda and Akira (2005) reported TLR2 as one of the 
most important TLRs, playing a crucial role in the recognition of pathogens where it binds to 
lipoproteins/lipopeptides, peptidoglycan from Gram-positive bacteria and lipoarabinomannan from 
mycobacteria. 
In our study, TLR2 was down-regulated by the wild type strain and was not significantly expressed by 
the mtp-mutant strain. However, this did not affect the recognition of M. tuberculosis as TLRJ and 
TLR6, which both functionally associate with TLR2 (Takeda and Akira, 2005), were up-regulated by 
both strains. TLR3 has been reported to be mainly involved in the recognition of double-stranded 
RNA produced by viruses during viral replication in host cells (Alexopoulou et al., 2001), therefore, 
this may explain why TLR3 was down-regulated by both strains in our study. The possible 
explanation for the down-regulation of TLR4 by both strains could be that these receptors interact with 
CD14 cells in order to mediate signal transduction events initiated by lipopolysaccharides (LPS) 
found in most Gram-negative bacteria (Hoshino et al., 1999). Moreever, LPS binds to the LPS-
binding protein which is present in serum, the LPS-LPS-binding protein complex forms and is 
subsequently recognized by CD14 which is preferentially expressed in neutrophils and macrophages 
(Takeda and Akira, 2003). LPS stimulation increases a physical proximity between TLR4 and CD14 
molecules, suggesting that TLR4 and CD14 may interact in LPS signalling (Jiang et al. 2000, Da 
Shilva Correia et al., 2001). TLR7 and TLR8 were up-regulated by both strains in our study, however, 
both were highly expressed in epithelial cells infected with the wild type strain. These findings could 
suggest that the presence of MTP in M. tuberculosis increases its recognition by host cells as TLR7 
and TLR8 have been predicted to recognize nucleic acid-like components of pathogens, especially 
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guanosine or uridine-rich single-stranded RNA from viruses such as HIV and influenza virus (Heil et 
al., 2004; Lund et al., 2004). An increased expression of TLRs and CD surface receptors by the wild 
type compared to the mutant strain suggests that MTP activates the induction of these receptors in 
epithelial cells which could lead to an increased recognition of the pathogen and induction of a strong 
immune response. 
4.3.2. MTP Induces the Expression of Chemokine Genes in Epithelial Cells 
Whilst the majority of genes associated with cytokine receptors and tumor necrosis factor (TNF) 
receptors were down-regulated by both strains, the wild type strain highly up-regulated genes coding 
for chemokine receptors compared to the mutant strain. MTP significantly affected differentially 
expressed genes associated with cytokines and chemokines as well as a pathway of differential 
regulation of cytokine production in macrophages and T helper cells, which were highly expressed by 
the wild type strain compared to the mutant strain. An IL6 upstream regulator was only enriched by 
the wild type strain. 
Our findings show an up-regulation of chemokines compared to cytokines by both strains. CCL2, 
CCL26, CCL28, CCL5, CXCLI, CXCL3, CXCL5, CXCL6 and CXCL9 chemokines and IL-11, IL-15, 
and IL-32 cytokines were highly up-regulated by the wild type strain compared to the mutant strain. 
These findings suggest that MTP highly induced the production of chemokines in A549 epithelial 
cells compared to cytokines. This is supported by previous findings in our group that MTP did not 
largely influence cytokine production in M. tuberculosis-infected epithelial cells (Ramsugit et al., 
2015). IL-1, IL-4, IL-6, IFN-r, and G-CSF were produced at low concentrations by epithelial cells at 
24, 48 and 72 hours post infection (Ramsugit et al., 2015). In our study, at 4 hr post infection, these 
cytokine genes were not expressed, except for IL-4 which was down-regulated. Ramsugit et al. (2015) 
speculated that MTP-mediated invasion of epithelial cells may be advantageous to M. tuberculosis by 
suppressing cytokine response which plays an essential role in the control of infections. This also 
supports the belief that the less harsh environment of epithelial cells may be a temporary safe haven 
for the pathogen to replicate in (Bermudez and Goodman, 1996; Mehta et al., 1996; Dobos et al., 
2000; Ryndak et al., 2015). 
In a previous study by our group, RNA-sequencing showed that ILIA, !LlB, IL8 and IL23A cytokines 
and CCL2, CCL5, CCL20, CXCLl and CXCL5 chemokines were up-regulated by A549 epithelial 
cells infected with the F15/LAM4/KZN strain of M tuberculosis at 48 hours post-infection (Mvubu et 
al. , 2016). Similarly, in the present study, CCL2, CCL5, CCL20, CXCLl and CXCL5 were highly up-
regulated by the wild type strain compared to the mutant strain. In contrast, ILIA, !LIB and IL23A 
cytokines were down-regulated by both strains. This difference could have been as a result of the 
study being conducted at an earlier time point ( 4 hours) and the previous study being aimed at the 
91 
regulation of canonical pathways, networks and transcriptional factors by different M. tuberculosis 
strains. These findings further suggest that MTP strongly mediates the immune response in A549 
epithelial cells through the induction of chemokine production. 
The role of epithelial cells in the expression of genes coding for cytokines (IL-6, IL-3 and PTX3) and 
chemokines (IL-8, CXCL2, CCL5, CCL2, MCP-1, CXCLJO and CXLl) had been demonstrated using 
microarray technology (Kim et al., 2013; Guerra-Laso et al., 2015) at 1, 2 and 4 hours post infection 
and RT-PCR (Yang et al., 2002; Miller et al., 2003) at 2, 9, 24, 48 and 72 hours post infection) 
previously. In our study, 4 hr post infection, these cytokines and chemokines were differentially 
expressed except for IL-3, IL-8, MCP-1 and CXCLlO which were not expressed at all. In comparison 
to Fll, Beijing, Unique and H37Rv strains of M tuberculosis, Fl5/LAM4/KZN strain induced a 
higher production of Rantes, IL-8, GM-CSF, IFN-y, G-CSF and TNF-a in A549 epithelial cells 48 
and 72 hr post infection (Mvubu et al., 2013). However, in our study, none of these cytokine and 
chemokine genes were expressed in epithelial cells 4 hours post infection, except for TNF-a. 
4.3.3. MTP Induces STAT Response and Cell Death in Epithelial Cells 
Our data shows that the presence of MTP elevated the up-regulation of genes coding for STATJ, 
STAT3 and STAT6 in epithelial cells compared to the mutant strain. These transcription regulators 
play an essential role in mediating gene expression as they are activated by cytokines, leading to 
phosphorylation and migration to the nucleus where they bind specific sequences that activate gene 
expression (Murray, 2007). Furthermore, activation of STATl (Sharma et al., 2007) and STAT2 
(Stockinger and Decker, 2009) transcriptional factors lead to an increased protective immune response 
in epithelial cells via the production of cytokines such as IFN-Y, which plays an essential role in 
antibacterial removal at the site of infection (Sharma et al., 2007). The increased expression of 
STATl, STAT3 and STAT6 by the wild type strain suggests that MTP plays an essential role in 
regulating gene expression in epithelial cells which could lead to an increased protective immune 
response against pathogens. 
Our gene expression profiles show that genes associated with tumor necrosis factor signalling were 
highly up-regulated in epithelial cells infected with the wild type strain compared to the mutant strain. 
These genes play a major role in controlling cell death which is either programmed by host cells in an 
attempt to deprive pathogens their replication niche or by pathogens themselves due to infection-
associated stress they impose on host cells (Welin, 2011). The induction of cell death by MTP in 
epithelial cells could suggest that M tuberculosis uses this adhesin as one of its virulence factors 
during infection in order to infect, replicate in and disseminate and colonize other host cells, upon cell 
death. 
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4.4. MTP does not Induce Antigen Presentation by Epithelial Cells 
Genes associated with antigen presentation were down-regulated by both strains in epithelial cells 
except for HLA-DMA and HLA-DMB. These findings are in line with the data that has been reported 
by Lin et al (1998), Peters and Ernst (2003) and Welin (2011) so far about the role of epithelial cells 
in antigen presentation. Epithelial cells are known to be involved in launching an immune response 
through the recognition of pathogens by surface-bound toll-like receptors (TLRs) and cytokine and 
chemokine production, which leads to the activation and recruitment of other immune cells towards 
the site of infection (Lin et al., 1998). Welin (2011) reported that presentation of antigens from 
extracellular pathogens is achieved through the uptake by antigen-presenting cells (APCs) such as 
macrophages, dendritic cells, natural killer cells and B cells. These antigens are then presented to 
CD8+ or CD4+ cells via MHC class I and II respectively, leading to the activation of the adaptive 
immune response. 
Our study showed that MTP plays no role in inducing the presentation of antigens by epithelial cells, 
as seen by the down-regulation of genes associated with this function. These findings do not correlate 
with those of Cunningham et al. (l 994) who reported that alveolar epithelial cells most likely play a 
role in antigen presentation via MHC class I molecules. However, it is important to mention that the 
lack of similarity may be due to this study being conducted on uninfected alveolar pulmonary 
epithelial cells. Mvubu et al. (2016) reported an increased expression of HLA-B, HLA-C, HLA-F and 
HLA-H genes in alveolar pulmonary epithelial cells infected with various M. tuberculosis strains for 
48 hours, in contrast to our findings. These differences could be attributed to the fact that our cells 
were sampled after 4 hours, suggesting that the expression of these genes occurs later in the infection 
process. 
4.5. MTP Induces the Expression of Networks in Alveolar Pulmonary Epithelial Cells 
Our network analysis showed that the wild type strain enriched a similar number of networks (25) 
when compared to the mtp-mutant strain. UBE2C and NR5A2 were the most up-regulated genes in 
biological networks induced by the wild type strain. UBE2C has been reported to be highly expressed 
in cancer cells where it causes chromosome missegregation and alters the cell cycle (Fujita et al., 
2009). This protein is also associated with aggressive thyroid (Guerriero et al., 2010), ovarian 
(Troncone et al., 2009) and breast cancer (Berlingieri et al., 2007). The overexpression of the gene 
coding for this protein in infected host cells may be indicative of a host cell response under stressful 
conditions. NR5A2 has been implicated in the reprogramming of somatic cells to pluripotent cells 
(Heng et al., 2010), an event which could be advantageous to host cells under bacterial or viral attack. 
The overexpression of both UBE2C and NR5A2 in epithelial cells infected with the wild type strain 
suggests that the presence of MTP may induce protective host cell response against M. tuberculosis. 
93 
The mtp-mutant strain highly up-regulated DEPDCJ and KLF2 in infected epithelial cells. Kanehira 
et al. (2007) reported the overexpression of DEPDCJ in bladder cancer cells. The overexpression of 
the gene coding for this protein in epithelial cells infected with the mutant strain could suggest a 
general host cell response to infection. The overexpression of KLF2 in monocytes inhibits LPS-
mediated activation of cytokines, chemokines and other pro-inflammatory factors (Das et al., 2006). 
The overexpression of this gene in epithelial cells infected with the mutant strain explains the reduced 
cytokine and chemokine response in these cells. Overall, the wild type strain enriched top scoring 
common networks in A549 epithelial cells compared to those enriched by the mtp-mutant strain. 
These findings further suggest that the absence of MTP in M tuberculosis does affect gene regulation 
in A549 epithelial cells, in response to mycobacterial infection. 
4.6. MTP Induces the Expression of Upstream Regulators in Epithelial Cells 
Our analysis of the enrichment of upstream regulators in infected epithelial cells revealed that the wild 
type strain activated the expression of essential upstream regulators in A549 epithelial cells, relative 
to uninfected cells. The STAT3 upstream regulator was up-regulated by the wild type strain and not 
significantly expressed by the mtp-mutant strain. Tkach et al. (2013) reported that in response to 
interferons, growth factors and cytokines, STAT3 transcriptional factors are phosphorylated and 
translocated to the nucleus where they activate transcription which leads to the expression of a variety 
of genes in response to cell stimuli. ST AT3 has also been reported to play a key role in cellular growth 
and apoptosis (Yuan et al., 2004), which plays a protective role against pathogens in host cells. 
Therefore, the high expression of STAT3 by the wild type strain could suggest the involvement of 
MTP in activating epithelial cells to induce a stronger host immune response against M. tuberculosis, 
through transcription activation. 
The CEBPD upstream regulator codes for a protein which is responsible for the regulation of genes 
involved in immune and inflammatory response and has been shown to strongly regulate IL-I and IL-
6 cytokines (Szpirer et al., 1992). Epithelial cells infected with M. tuberculosis have been reported to 
produce IL-1 f3 and IL-6, even though these cytokines are produced at low concentrations before 72 
hour post infection (Ramsugit et al., 2016). The up-regulation of CEBPD by the wild type strain 
suggests the involvement of MTP in the activation of cytokine production in epithelial cells. 
The mutant strain exclusively enriched 24 upstream regulators in A549 pulmonary epithelial cells. 
MYBL2 was the only highly up-regulated upstream regulator. A similar trend was also observed in 
down-regulated upstream regulators where MYC was the only highly down-regulated regulator. The 
MYC upstream regulator codes for proteins involved in cell cycle division, cellular transformation and 
apoptosis (Finver et al., 1988). The wild type strain exclusively enriched 10 upstream regulators in 
A549 pulmonary epithelial cells. HGF was the highest up-regulated upstream regulator followed by 
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IL6 whereas ESRJ was the lowest up-regulated. HGF is a growth factor that is produced in stromal 
cells and has been reported to be associated with epithelial cell proliferation, motility and 
morphogenesis (Nakamura and Mizonu, 2010). It is also responsible for the self- repair of injured 
lungs, kidneys and livers (Nakamura and Mizonu, 2010), which could explain its up-regulation by the 
wild type strain in alveolar pulmonary epithelial cells. These findings could imply that the presence of 
MTP may lead to increased cytotoxicity of M tuberculosis to pulmonary epithelial cells. 
4.7. Significance of the Findings 
One of the main problems associated with the development of rapid point of care (POC) TB 
diagnostic tests and therapeutic interventions is the lack of biomarkers that can be targeted for this 
purpose. Our findings confirm previous reports that support MTP as a biomarker for the potential 
development of anti-TB drugs and POC diagnostic test, as they' re surface-located and have been 
shown to play an important role in adherence to and invasion of host immune cells. Our findings also 
strongly suggest that MTP has the ability to induce host immune response in epithelial cells, making it 
an essential antigen and immunogen for M. tuberculosis and thus, a potential vaccine candidate or 
immunotherapeutic agent as adjunct therapy for TB. 
4.8. Limitations of the Study 
The cost of RNA-sequencing technology was the major limiting factor of our study. The number of 
biological and technical replicates is an important factor of the study design in RNA-sequencing 
experiments. In this study, only biological replicates were included due to the expensive nature of 
RNA-seq. In addition, samples from only one (4 hours) of the four time intervals investigated were 
sequenced. Sequencing of a sample at a later time interval would have allowed for the comparison of 
two sets of gene expressions profiles in epithelial cells during the early innate response and early 
adaptive immune response in vitro. Samples had to be sequenced using the multiplexing method 
which involves processing a large number of samples at once and can sometimes decrease the overall 
read mapping rate to the reference genome. However, these sequencing-related limitations were 
compensated for by employing deep core sequencing with a large coverage which permitted higher 
transcript detection and increased quantification. The lack of bioinformatics skills was also a major 
limiting factor as it caused major delays in the analysis of huge amounts of data. RNA-seq data has 
not yet been validated using RT-PCR. However, a previous study by our research group (Mvubu et 
al., 2016), as well as other studies (Arnvig et al., 2011; Uplekar et al., 2012; Chen et al., 2015; 
Rienksma et al., 2015) reported good correlation of RNA-Seq data with RT-qPCR. 
4.9. Recommendations for Future Studies 
The RNA-Seq data will be validated by RT-qPCR of a selected number of genes in the near future. 
Since RNA-Seq is expensive, gene expression profiles of host immune response-related genes such as 
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genes coding for cytokines, antigen presentation and granuloma formation should be interrogated at 
different time intervals using RT-qPCR to understand the kinetics of expression. RT-qPCR will also 
be applied in RNA extracted from A549 epithelial cells infected with the mtp-complemented strain in 
order to confirm if the observed phenotypes are reversed to wild type levels. Northern blot 
hybridization could also be applied to study and confirm gene expression profiles. According to Ding 
et al. (2007), northern blotting is a gold standard method for confirming gene expression data 
generated by microarrays when compared to RT-qPCR. It does not involve enzymatic manipulation of 
RNA and this is critical as it eliminates artificial changes that are introduced during RNA processing. 
Whole transcriptome analysis of the mtp gene deletion mutant relative to the wild type M 
tuberculosis infecting host cells such as A549 epithelial cells, THPI-derived macrophages as well as 
mouse organs would elucidate the pathogen genes that are regulated by MTP and further inform on 
how different host environments respond to M. tuberculosis infection. 
4.10. Conclusion 
This is the first study to investigate the role of MTP in gene regulation of epithelial cells using RNA-
sequencing technology. In the absence of MTP, the number of significantly differentially expressed 
genes and canonical pathways induced in A549 alveolar epithelial cells was reduced. Our findings 
further showed that alveolar epithelial cells infected with the wild type strain launched a stronger host 
immune response when compared to those infected with the mtp-knockout mutant strain. Taken 
together, these findings suggest that MTP affects gene regulation of A549 alveolar epithelial cells and 
could be a potential TB vaccine candidate and antimicrobial drug target. The presence of MTP also 
allowed the enrichment of a high number of pathways compared to its absence, including those 
associated with the host immune response such as the complement system, cell surface receptor 
signalling, STAT signalling, TLR signalling, TNF response signalling and cytokine and chemokine 
production. These findings add to the growing evidence that M tuberculosis uses MTP as one of its 
major invasins and virulence factors during the infection of host cells. Our data also confirms that 
epithelial cells do not provide just a physical barrier against extracellular objects, but they also play an 
important role in host immune response to infections. 
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APPENDICES 
1. Bacterial colony forming units (CFUs) obtained before (initial inoculums) and after 
(final) infection of A549 epithelial cells with the wild type and mutant strain for 4 hours. 

































2. Canonical pathways enriched by the wild type strain in A549 epithelial cells. 
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3. -log (p value) of canonical pathways enriched by the wild type strain in A549 epithelial 
cells. Pathways in red were uniquely enriched by the wild type strain. 
Pathway -log (p-value) 
Cell Cycle Control of Chromosomal Replication 5.513 
Mitotic Role of Polo-like Kinase 4.702 
Cell Cycle: G2/M DNA Damage Checkpoint Regulation 3.506 
Extrinsic Prothrombin Activation Pathway 3.48 
Ethanol Degradation II 3.002 
ATM Signaling 2.95 
Acute Phase Response Signaling 2.908 
Coagulation System 2.869 
LXRIRXR Activation 2.675 
Role of CHK Proteins in Cell Cycle Checkpoint Control 2.485 
FXRIRXR Activation 2.431 
Intrinsic Prothrombin Activation Pathway 2.412 
GADD45 Signaling 2.392 
DNA Damage-Induced 14-3-3a Signaling 2.392 
Human Embryonic Stem Cell Pluripotency 2.38 
Embryonic Stem Cell Differentiation into Cardiac Lineages 2.347 
Phenylethylamine Degradation I 2.221 
Cyclins and Cell Cycle Regulation 2.198 
Role of Tissue Factor in Cancer 2.178 
Hepatic Fibrosis/Hepatic Stellate Cell Activation 2.135 
Ovarian Cancer Signaling 2.089 
Estrogen-mediated S-Phase Entry 2.015 
Serotonin Degradation 1.993 
Notch Signaling 1.967 
Complement System 1.967 
Colorectal Cancer Metastasis Signaling 1.884 
Noradrenaline and Adrenaline Degradation 1.877 
Hereditary Breast Cancer Signaling 1.721 
Role of BRCAl in DNA Damage Response 1.674 
VDRIRXR Activation 1.647 
._ .. 
Role of Oct4 in Mammalian Embryonic Stem Cell Pluripotency 1.631 
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Differential Regulation of Cytokine Production in Macrophages and T helper Cells 
ERK.5 Signaling 
Airway Pathology in Chronic Obstructive Pulmonary Disease 
Ethanol Degradation IV 
LPS/IL-1 mediated fuhibition of RXR Function 
IL-17 A Signaling in Fibroblasts 
a-tocopherol Degradation 
Urate Biosynthesis /Inosine 5'-phosphate Degradation 
Guanosine Nucleotides Degradation III 
Fatty Acid a-oxidation 
Pyruvate Fermentation to Lactate 
Pyridoxal 5'-phosphate Salvage Pathway 
Role of IL-17 A in Arthritis 
4. Canonical pathways enriched by the mutant strain in A549 epithelial cells. 
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5. -log (p value) of canonical pathways enriched by the mutant strain in A549 epithelial 
cells. Pathways in red were uniquely enriched by the mutant strain. 
Pathway log (p-value) 
Cell Cycle Control of Chromosomal Replication 5.973 
Mitotic Role of Polo-like Kinase 5.281 
Extrinsic Prothrombin Activation Pathway 4.036 
Cell Cycle: G2/M DNA Damage Checkpoint Regulation 3.926 
LXR/RXR Activation 3.423 
ATM Signaling 3.352 
Coagulation System 3.188 
Acute Phase Response Signaling 3.095 
Complement System 3.055 
Role of CHK Proteins in Cell Cycle Checkpoint Control 2.832 
Intrinsic Prothrombin Activation Pathway 2.747 
Role of Tissue Factor in Cancer 2.658 
GADD45 Signaling 2.614 
DNA Damage-Induced 14-3-3a Signaling 2.614 
VDR/RXR Activation 2.551 
Cyclins and Cell Cycle Regulation 2.551 
a-tocopherol Degradation 2.259 
FXRIRXR Activation 2.234 
Estrogen-mediated S-Phase Entry 2.229 
Hereditary Breast Cancer Signaling 2.164 
Role ofBRCAl in DNA Damage Response 1.981 
p53 Signaling 1.956 
Pyridoxal 5'-phosphate Salvage Pathway 1.851 
Differential Regulation of Cytokine Production in Macrophages and T helper 1.769 
Cells 
IL-17 A Signaling in Fibroblasts 1.652 
Ethanol Degradation II 1.652 
Salvage Pathways of Pyrimidine Deoxyribonucleotides 1.626 
Glioma Invasiveness Signaling 1.505 
Ethanol Degradation N 1.482 
LPS/IL-1 mediated Inhibition of RXR Function 1.368 
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6. Confirmation of mtp deletion by PCR (Ramsugit et al., 2013). 
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(d) 1 l 
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l.'" 
Construction of the mtp deletion mutant by allelic replacement and its confirmation. (a) Chromosomal 
organization of the wild type strain (upper) and mtp-mutant strain (lower), in which the mtp gene has 
been disrupted by a hygR-sacB cassette. (b, c) Confinnation of the mtp-knockout mutant by PCR. (d) 
Southern blot showing digested genomic DNA of the wild type (Lane 1) and mtp-mutant (Lane 2). 
7. Mechanistic networks of upstream regulators that were commonly induced by both 





NFkB "" , plex) 
CCNDl E2Fl 









I I \ ' 
I I \ ' 
I I \ ', 
/ I \ \ 
I I \ ' 
/ I \ \ 













' ' ' ' ' 
SMARCA4 
TP53 




8. Mechanistic networks of upstream regulators that were uniquely induced by the wild 
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9. Mechanistic networks of upstream regulators that were uniquely induced by the wild 







I I \ 
I I \ 





















































~~1 Histone h3 
I /\ /ff\\ 
I I I I \ /; I I\ 
I I I \ /;I I' 
I
/ II I \ // I I \ \ 
I \ /I I I\ 
I I I I I I 
J + ~ kl\ ~ ~ ~ \ 





















































"' I I 
I I 
/ I 
.. ~t- ~ 
(, E2F5 .J ( CBXJ) 
YYl 
....... -.... ......... 
STA Tl 
-.... __ _ 




---- J ___ .-- I 
-- J -- ,, 
(~;.--- .. 
131 
TP63 
-------
132 
